Top

Ann H. Klopp, M.D., Ph.D.

Department of Radiation Oncology, Division of Radiation Oncology

About Dr. Klopp

Ann Klopp is a Professor of Radiation Oncology at The University of Texas MD Anderson Cancer Center. She leads the gynecologic section in the Department of Radiation Oncology and serves as the Director of Brachytherapy. Her clinical research is focused on the use of advanced radiation techniques to reduce toxicity from radiation treatment and improve outcomes for women with gynecologic cancers. To accomplish this, she has expanded the use of intraprocedural CT and MRI for brachytherapy to facilitate the use of advanced brachytherapy applicators. MD Anderson is the only site in the US offering both inpatient and outpatient brachytherapy. Additionally, she led a phase III randomized trial demonstrating that IMRT reduces the toxicity of pelvic radiation. Dr. Klopp’s lab is focused on understanding effects of the microenvironment on the biology of gynecologic cancers, including host stromal cells which infiltrate cancers and microbial organisms which infect mucosal cancers. She co-leads the MD Anderson moonshot program for HPV cancers aimed at improving outcomes through targeted molecular and immunologic treatments. She has national leadership roles including co-chairing the corpus committee at NRG and chairing the oral boards for gynecologic cancers through the American Board of Radiology.

4 questions about COVID-19 vaccines and bivalent boosters, answered

Present Title & Affiliation

Primary Appointment

Executive Section Chief, Gynecology, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Director of Brachytherapy, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Director of Gynecologic Services, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Interests

Ann Klopp is an Assistant Professor of Radiation Oncology at the University of Texas MD Anderson Cancer Center. She is a physician-scientist specializing in treatment of gynecologic cancers with protected time devoted to laboratory research. Clinically, she is interested in the management of high-risk endometrial cancers and the use of advanced radiation techniques to minimize toxicity. She is a member of the steering committee at RTOG, the Corpus Committee at GOG and the Uterine Task Force at NIH so she is well positioned to translate research findings into clinical trials. Her post-doctoral research focused on mesenchymal stem cell engraftment in the tumor micorenvironment with Dr. Frank Marini and Dr. Michael Andreeff at MD Anderson. Her current laboratory research is focused on the role of obesity and visceral adipose derived stem cells on endometrial and ovarian cancers using both clinical specimens and murine models. Future studies will focus on identifying the mechanisms by which omental adipose stem cells promote endometrial and ovarian cancer with the ultimate goal of developing translational approaches to disrupt these interactions.

Education & Training

Degree-Granting Education

2003	Medical College of Wisconsin, Milwaukee, Wisconsin, US, MD
2002	Medical College of Wisconsin, Milwaukee, Wisconsin, US, Ph.D. in Microbiology and Molecular Biology
1996	University of Michigan, Ann Arbor, Michigan, US, BS in Microbiology

Postgraduate Training

2006-2007	Research Fellowship, Tumor Microenvironment, The University of Texas MD Anderson Cancer Center, Houston, Texas
2004-2008	Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
2003-2004	Clinical Internship, Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin

Board Certifications

2023	Drug Enforcement Administration
2009	American Board of Radiology

Experience & Service

Academic Appointments

Associate Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2021

Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2015

Administrative Appointments/Responsibilities

Medical Director, COVID Vaccine Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2021 - 2023

Center Medical Director, Mays Clinic, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 2018 - 2021

Section Chief, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 2017 - 2023

Associate Medical Director, Mays Clinic, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2018

Other Appointments/Responsibilities

Research Technician, University of Michigan, Ann Arbor, MI, 1992 - 1997

Institutional Committee Activities

Member, Chair for the Division of Anesthesiology Search Committee, 2021 - Present

Member, Multidisciplinary Research Advisory Committee (MRAC), 2016 - Present

Vice Chair, Distinguished Alumni Subcommittee, 2013 - 2015

Member, Chair for the Department of Gynecologic Oncology & Reproductive Medicine in the Division of Surgery Search Committee, 2011 - 2012

Member, Odyssey Program Advisory Committee, 2011 - 2014

Committee Member, Psychosocial, Behavioral, and Health Services Research Committee, 2010 - 2012

Honors & Awards

	Angel Award for Academic Achievement, University of Michigan
	Department of Microbiology Trainee Travel Award, Medical College of Wisconsin
	Maurice Greenberg Award for Graduate Pursuing Radiation Oncology, Medical College of Wisconsin
	Young Oncologist Essay Award, American Radium Society
	Fletcher Award for Best Resident Manuscript, The University of Texas MD Anderson Cancer Center, Department of Radiation Oncology
	Roentgen Award from RSNA for Resident Research, The University of Texas MD Anderson Cancer Center, Department of Radiation Oncology
	National AAWR Eleanor Montague Distinguished Resident Award in Radiation Oncology, AAWR
	Golden Apple for Mentoring Excellence, Radiation Oncology Resident Class of 2014
	The James D. Cox Mentoring Award, The University of Texas MD Anderson Cancer Center, The Department of Radiation Oncology
	The Gunar K. Zagars Teaching Award, The University of Texas MD Anderson Cancer Center, The Department of Radiation Oncology
	Top Performer, Physicians Referral Services

Selected Publications

Peer-Reviewed Articles

Klopp AH, Xiao W, Gjyshi O, Yoshida-Court K, Wei P, Swanson D, Cisneros Napravnik T, Grippin A, Venkatesan AM, Jacobsen MC, Fuentes DT, Lynn E, Sammouri J, Jhingran A, Joyner M, Lin LL, Colbert LE, Gillison ML, Klopp AH. Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation. Clin Cancer Res None(None):None. e-Pub 2024. PMID: 39680029.
Andring LM, Corrigan KL, Reeve B, Meyer L, Wang XS, Smith G, Bailard N, Domingo M, Fellman B, Varkey J, Foster-Mills T, Lin L, Jhingran A, Colbert L, Eifel P, Klopp AH, Joyner M. The Value of Patient-Reported Outcomes to Predict Symptom Burden and Health-Related Quality of Life After Chemoradiation for Cervical Cancer: A Prospective Study. Pract Radiat Oncol 14(5):e353-e361, 2024. PMID: 38825227.
Klopp AH, Enserro D, Powell M, Randall M, Schink JC, Mannel RS, Holman L, Bender D, Kushnir CL, Backes F, Zweizig SL, Waggoner S, Bradley KA, Lawrence LD, Hanjani P, Darus CJ, Jr WS, Cardenes HR, Feddock JM. Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial. J Clin Oncol 42(20):2425-2435, 2024. e-Pub 2024. PMID: 38662968.
Kim M, Maldonado JA, Pandey P, El Alam MB, Kouzy R, Christopherson K, Minsky BD, Nugyen QN, Grosshans D, Lin LL, Mitchell MP, Klopp AH, Lee PP, Bird J, Satcher R, Lewis VO, Lin PP, Tang C, Koong AC, Moon B, Colbert LE. Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic. BMJ Support Palliat Care None(None):None, 2024. PMID: 38843933.
Kucera, CW, Chappell, NP, Tian, C, Richardson, MT, Tarney, CM, Hamilton, CA, Chan, J, Kapp, DS, Leath, CA, Casablanca, Y, Rojas, C, Sitler, CA, Wenzel, L, Klopp, AH, Jones, NL, Rocconi, RP, Farley, JH, O'Connor, TD, Shriver, CD, Bateman, NW, Conrads, TP, Phippen, NT, Maxwell, GL, Darcy, KM. Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors. Gynecologic oncology 184:224-235, 2024. PMID: 38340648.
Wang, L, Ding, Y, Bruno, TL, Stafford, RJ, Lin, E, Bathala, TK, Sanders, JW, Ning, M, Ma, J, Klopp, AH, Venkatesan, AM, Wang, J, Martirosyan, KS, Frank, SJ. A Novel Positive-Contrast Magnetic Resonance Imaging Line Marker for High-Dose-Rate (HDR) MRI-Assisted Radiosurgery (MARS). Cancers 16(10), 2024. PMID: 38792000.
Kopelman, ZA, Tian, C, Tumas, J, Phippen, NT, Tarney, CM, Hope, ER, Winkler, SS, Jokajtys, S, Kucera, CW, Chan, J, Richardson, MT, Kapp, DS, Hamilton, CA, Leath, CA, Jones, NL, Rocconi, RP, Farley, J, Secord, AA, Cosgrove, C, Powell, MA, Klopp, AH, Walker, JL, Fleming, GF, Bateman, NW, Conrads, TP, Maxwell, GL, Darcy, KM. Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials. Gynecologic oncology 183:103-114, 2024. PMID: 38593674.
Manzar, GS, Alam, MB, Lynn, EJ, Karpinets, T, Harris, TA, Lo, DK, Yoshida-Court, K, Napravnik, TC, Sammouri, J, Lin, D, Andring, L, Bronk, JK, Wu, X, Sims, TT, Mathew, GG, Schmeler, KM, Eifel, PJ, Jhingran, A, Lin, LL, Joyner, MM, Zhang, J, Futreal, A, Klopp, AH, Colbert, LE. Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy. Brachytherapy 23(2):123-135, 2024. PMID: 38129211.
Brower, JV, Bregar, AJ, Klopp, AH. Path to Precision. Practical radiation oncology 14(2):154-160, 2024. PMID: 38048989.
Sitler, CA, Tian, C, Hamilton, CA, Richardson, MT, Chan, J, Kapp, DS, Leath, CA, Casablanca, Y, Washington, C, Chappell, NP, Klopp, AH, Shriver, CD, Tarney, CM, Bateman, NW, Conrads, TP, Maxwell, GL, Phippen, NT, Darcy, KM. Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States. Cancers 16(5), 2024. PMID: 38473428.
Iwase, T, Parikh, A, Wenli, D, Shen, Y, Adams, DL, Tang, CM, Cohen, E, Reuben, JM, Shrimanker, TV, Chainitikun, S, Kida, K, Singareeka Raghavendra, A, Sapon, ME, Sahin, O, James, A, Sridhar, N, Klopp, AH, Tripathy, D, Ueno, NT. Circulating cancer-associated macrophage-like cells and macrophage-related cytokines in obese patients with advanced breast cancer who undergo neoadjuvant chemotherapy. Journal of Cancer 15(18):5855-5862, 2024. PMID: None.
Yoder, AK, Lakomy, DS, Wu, J, Andring, LM, Corrigan, KL, Fellman, B, Jhingran, A, Klopp, AH, Colbert, LE, Soliman, PT, Frumovitz, M, Peterson, SK, Lin, LL. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy 23(1):1-9, 2024. PMID: 37914588.
Sammouri, J, Venkatesan, AM, Lin, L, Jhingran, A, Klopp, AH, Joyner, MM, Eifel, PJ, Colbert, LE. Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement. Gynecologic oncology 180:24-34, 2024. PMID: 38041900.
Iwase T, Parikh A, Wenli D, Shen Y, Adams DL, Tang CM, Cohen EN, Reuben JM, Shrimanker TV, Chainitikun S, Kida K, Raghavendra AS, Sapon ME, Sahin O, James A, Sridhar N, Klopp AH, Tripathy D, Ueno NT. Circulating cancer-associated macrophage-like cells and macrophage-related cytokines in obese patients with advanced breast cancer who undergo neoadjuvant chemotherapy. J Cancer 15(18):5855-5862, 2024. PMID: 39440056.
Gay SS, Kisling KD, Anderson BM, Zhang L, Rhee DJ, Nguyen C, Netherton T, Yang J, Brock K, Jhingran A, Simonds H, Klopp A, Beadle BM, Court LE, Cardenas CE. Identifying the optimal deep learning architecture and parameters for automatic beam aperture definition in 3D radiotherapy. J Appl Clin Med Phys 24(12):e14131, 2023. e-Pub 2023. PMID: 37670488.
Colbert L, El Alam M, Karpinets T, Lynn E, Lo D, Wang R, Harris T, Elnaggar J, Yoshida-Court K, Tomasic K, Bronk J, Sammouri J, Yanamandra A, Olvera A, Carlin L, Sims T, Singh S, Martinez S, Tan L, Mahmud I, Lorenzi P, Delgado Medrano A, Lin D, Abana C, Li H, Eifel P, Jhingran A, Joyner M, Lin L, Ramondetta L, Futreal A, Schmeler K, Mathew G, Dorta-Estremera S, Zhang J, Wu X, Ajami N, Taniguchi C, Petrosino J, Sastry J, Okhuysen P, Yee C, Wargo J, Klopp A. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancel Cell 41(11):1945-1962.e11, 2023. PMID: 37863066.
Hathout L, Erickson B, Gehrig P, Harkenrider M, Klopp A, Small W. Can Immunotherapy Replace Radiation in Locally Advanced Endometrial Cancer?: Treatment for Advanced Endometrial Cancer. Pract Radiat Oncol 13(6):551-557, 2023. e-Pub 2023. PMID: 37442429.
Jacobsen MC, Rigaud B, Simiele SJ, Rauch GM, Ning MS, Vedam S, Klopp AH, Stafford RJ, Brock KK, Venkatesan AM. Feasibility of quantitative diffusion-weighted imaging during intra-procedural MRI-guided brachytherapy of locally advanced cervical and vaginal cancers. Brachytherapy 22(6):736-745, 2023. e-Pub 2023. PMID: 37612174.
Andring LM, Corrigan KL, Rooney M, Bailard N, Domingo M, Fellman B, Varkey J, Foster-Mills T, Kazantsev T, Lin L, Jhingran A, Colbert L, Eifel P, Klopp AH, Joyner M. Patient reported outcomes for women undergoing definitive chemoradiation for gynecologic cancer: A prospective clinical trial. Pract Radiat Oncol 13(6):e538-e546, 2023. e-Pub 2023. PMID: 37597615.
Sammouri J, Wong MC, Lynn EJ, El Alam MB, Lo DK, Lin D, Harris TH, Karpinets TV, Court K, Napravnik TC, Wu X, Zhang J, Klopp AH, Ajami NJ, Colbert LE. Serial Genotyping of the Human Papillomavirus in Cervical Cancer: An Insight Into Virome Dynamics During Chemoradiation Therapy. Int J Radiat Oncol Biol Phys 116(5):1043-1054, 2023. e-Pub 2023. PMID: 36801350.
Konski A, Deshmukh S, Klopp AH, Yeung AR, Westin SN, Thompson JS, Doncals DE, Cantuaria GHC, D'Souza DP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW. Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203. Gynecol Oncol 175:176-181, 2023. e-Pub 2023. PMID: 37393743.
Gjyshi O, Grippin A, Andring L, Jhingran A, Lin LL, Bronk J, Eifel PJ, Joyner MM, Sastry JK, Yoshida-Court K, Solley TN, Napravnik TC, O'Hara MP, Hegde VL, Colbert LE, Klopp AH. Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer. Clin Transl Radiat Oncol 39:100578, 2023. e-Pub 2023. PMID: 36935860.
Teka B, Yoshida-Court K, Firdawoke E, Chanyalew Z, Gizaw M, Addissie A, Mihret A, Colbert LE, Napravnik TC, El Alam MB, Lynn EJ, Mezzari M, Anuja J, Kantelhardt EJ, Kaufmann AM, Klopp AH, Abebe T. Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian Women. Microorganisms 11(4), 2023. e-Pub 2023. PMID: 37110255.
Yoder AK, Lakomy DS, Wu J, Andring LM, Fellman B, Colbert LE, Jhingran A, Klopp AH, Soliman P, Peterson SK, Lin LL. Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors. Clin Oncol (R Coll Radiol) 35(2):e215-e226, 2023. e-Pub 2022. PMID: 36494250.
Yoshida-Court K, Karpinets TV, Mitra A, Solley TN, Dorta-Estremera S, Sims TT, Delgado Medrano AY, El Alam MB, Ahmed-Kaddar M, Lynn EJ, Sastry KJ, Zhang J, Futreal A, Nick A, Lu K, Colbert LE, Klopp AH. Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer. PLoS One 18(1):e0279590, 2023. e-Pub 2023. PMID: 36607962.
Elnaggar JH, Huynh VO, Lin D, Hillman RT, Abana CO, El Alam MB, Tomasic KC, Karpinets TV, Kouzy R, Phan JL, Wargo J, Holliday EB, Das P, Mezzari MP, Ajami NJ, Lynn EJ, Minsky BD, Morris VK, Milbourne A, Messick CA, Klopp AH, Futreal PA, Taniguchi CM, Schmeler KM, Colbert LE. HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development. Front Immunol 14:1051431, 2023. e-Pub 2023. PMID: 37063829.
Netherton TJ, Nguyen C, Cardenas CE, Chung C, Klopp AH, Colbert LE, Rhee DJ, Peterson CB, Howell R, Balter P, Court LE. An automated treatment planning framework for spinal radiotherapy and vertebral level second check. Int J Radiat Oncol Biol Phys 114(3):516-528, 2022. e-Pub 2022. PMID: 35787928.
Chino J, Yashar C, Klopp A, Viswanathan A. Limiting Access to Abortion Will Potentially Harm Patients With Gynecologic Cancers. Int J Radiat Oncol Biol Phys 114(3):396-398, 2022. e-Pub 2022. PMID: 35963471.
Harkenrider MM, Abu-Rustum N, Albuquerque K, Bradfield L, Bradley K, Dolinar E, Doll CM, Elshaikh M, Frick MA, Gehrig PA, Han K, Hathout L, Jones E, Klopp A, Mourtada F, Suneja G, Wright AA, Yashar C, Erickson BA. Radiation Therapy for Endometrial Cancer: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol 13(1):41-65, 2022. e-Pub 2022. PMID: 36280107.
Karpinets TV, Wu X, Solley T, El Alam MB, Sims TT, Yoshida-Court K, Lynn E, Ahmed-Kaddar M, Biegert G, Yue J, Song X, Sun H, Petrosino JF, Mezzari MP, Okhuysen P, Eifel PJ, Jhingran A, Lin LL, Schmeler KM, Ramondetta L, Ajami N, Jenq RR, Futreal A, Zhang J, Klopp AH, Colbert LE. Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure. BMC Cancer 22(1):945, 2022. e-Pub 2022. PMID: 36050658.
Yeung AR, Deshmukh S, Klopp AH, Gil KM, Wenzel L, Westin SN, Konski AA, Gaffney DK, Small W, Thompson JS, Doncals DE, Cantuaria GHC, D'Souza DP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW. Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial. J Clin Oncol 40(27):3115-3119, 2022. e-Pub 2022. PMID: 35960897.
Wu J, Lakomy DS, Fellman BM, Salcedo MP, Sood AK, Jhingran A, Klopp AH, Iyer RB, Jimenez C, Colbert LE, Eifel PJ, Schmeler KM, Lin LL. Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment. Pract Radiat Oncol 12(5):e423-e433, 2022. e-Pub 2022. PMID: 35390531.
Lin D, El Alam MB, Jaoude JA, Kouzy R, Phan JL, Elnaggar JH, Resendiz B, Medrano AYD, Lynn EJ, Nguyen ND, Noticewala SS, Mathew GG, Holliday EB, Minsky BD, Das P, Morris VK, Eng C, Mezzari MP, Petrosino JF, Ajami NJ, Klopp AH, Taniguchi CM, Colbert LE. Microbiome Dynamics During Chemoradiation Therapy for Anal Cancer. Int J Radiat Oncol Biol Phys 113(5):974-984, 2022. e-Pub 2022. PMID: 35513187.
Jacobsen MC, Beriwal S, Dyer BA, Klopp AH, Lee SI, McGinnis GJ, Robbins JB, Rauch GM, Sadowski EA, Simiele SJ, Stafford RJ, Taunk NK, Yashar CM, Venkatesan AM. Contemporary image-guided cervical cancer brachytherapy: Consensus imaging recommendations from the Society of Abdominal Radiology and the American Brachytherapy Society. Brachytherapy 21(4):369-388, 2022. e-Pub 2022. PMID: 35725550.
Lakomy DS, Yang J, Vedam S, Wang J, Lee B, Sobremonte A, Castillo P, Hughes N, Mohammedsaid M, Jhingran A, Klopp AH, Choi S, Fuller CD, Lin LL. Clinical implementation and initial experience with a 1.5 Tesla MR-linac for MR-guided radiotherapy for gynecologic cancer: An R-IDEAL stage 1/2a first in humans/feasibility study of new technology implementation. Pract Radiat Oncol 12(4):e296-e305, 2022. e-Pub 2022. PMID: 35278717.
Lakomy DS, Yoder AK, Wu J, Hernandez M, Ayoola-Adeola M, Jhingran A, Klopp A, Soliman P, Peterson SK, Lin LL. Impact of treatment modality on pelvic floor dysfunction among uterine cancer survivors. Int J Gynecol Cancer 32(10):1266-1275, 2022. e-Pub 2022. PMID: 35680139.
Nguyen, A, Kim, S, Keyes, M, Petereit, DG, Mourtada, F, Rossi, PJ, Klopp, AH, Kamrava, M. Evaluation of burnout in physician members of the American Brachytherapy Society. Brachytherapy 21(3):362-368, 2022. PMID: 35249823.
Lakomy DS, Wu J, Chapman BV, Yu ZH, Lee B, Klopp AH, Jhingran A, Eifel PJ, Lin LL. Use of specific duodenal dose constraints during treatment planning reduces toxicity after definitive para-aortic radiotherapy for cervical cancer. Pract Radiat Oncol 12(3):e207-e215, 2022. e-Pub 2021. PMID: 34958984.
Wiley, R, Bondre, IL, Jalloul, RJ, Klopp, AH, Taylor, JS, Ramondetta, LM. Definitive vs palliative pelvic radiation for patients with newly diagnosed stage IVB cervical cancer treated with bevacizumab – An exploratory study. Gynecologic Oncology Reports 40, 2022. PMID: 35345549.
Corrigan KL, Yoder A, De B, Lin L, Jhingran A, Joyner MM, Eifel PJ, Colbert LE, Lu KH, Klopp AH. Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis. Gynecol Oncol 164(3):550-557, 2022. e-Pub 2021. PMID: 34974906.
Colbert LE, El MB, Lynn EJ, Bronk J, Karpinets TV, Wu X, Chapman BV, Sims TT, Lin D, Kouzy R, Sammouri J, Biegert G, Delgado Medrano AY, Olvera A, Sastry KJ, Eifel PJ, Jhingran A, Lin L, Ramondetta LM, Futreal AP, Jazaeri AA, Schmeler KM, Yue J, Mitra A, Yoshida-Court K, Wargo JA, Solley TN, Hegde V, Nookala SS, Yanamandra AV, Dorta-Estremera S, Mathew G, Kavukuntla R, Papso C, Ahmed-Kaddar M, Kim M, Zhang J, Reuben A, Holliday EB, Minsky BD, Koong AC, Koay EJ, Das P, Taniguchi CM, Klopp A. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers. Cancer Immunol Res 10(2):259-271, 2022. e-Pub 2022. PMID: 35045973.
Bronk JK, Kapadia C, Wu X, Chapman BV, Wang R, Karpinets TV, Song X, Futreal AM, Zhang J, Klopp AH, Colbert LE. Feasibility of a novel non-invasive swab technique for serial whole-exome sequencing of cervical tumors during chemoradiation therapy. PLoS One 17(10):e0274457, 2022. e-Pub 2022. PMID: 36201462.
Maheshwari E, Nougaret S, Stein EB, Rauch GM, Hwang KP, Stafford RJ, Klopp AH, Soliman PT, Maturen KE, Rockall AG, Lee SI, Sadowski EA, Venkatesan AM. Update on MRI in Evaluation and Treatment of Endometrial Cancer. Radiographics 42(7):220070, 2022. e-Pub 2022. PMID: 36018785.
Boyce-Fappiano D, Nguyen KA, Gjyshi O, Manzar G, Abana CO, Klopp AH, Kamrava M, Orio PF, Thaker NG, Mourtada F, Venkat P, Chang AJ. Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities. JCO Oncol Pract 17(12):OP2100291, 2021. e-Pub 2021. PMID: 34550749.
Anakwenze Akinfenwa CP, Ibraheem A, Nwankwo K, Lasebikan N, Ali-Gombe M, Aliyu UM, Ikhile E, Adegboyega O, Abdullahi A, Klopp AH, Schmeler K, Lin LL, Jhingran A, Page BR, Leng J, Grover S, Ntekim A. Emerging Use of Public-Private Partnerships in Public Radiotherapy Facilities in Nigeria. JCO Glob Oncol 7:1260-1269, 2021. PMID: 34351813.
Ning MS, Das P, Rosenthal DI, Dabaja BS, Liao Z, Chang JY, Gomez DR, Klopp AH, Gunn GB, Allen PK, Nitsch PL, Natter RB, Briere TM, Herman JM, Wells R, Koong AC, McAleer MF. Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care. J Natl Compr Canc Netw 19(7):1-9, 2021. e-Pub 2021. PMID: 33878727.
Biegert G, El Alam MB, Karpinets T, Wu X, Sims TT, Yoshida-Court K, Lynn EJ, Yue J, Medrano AD, Petrosino J, Mezzari MP, Ajami NJ, Solley T, Ahmed-Kaddar M, Klopp AH, Colbert LE. Diversity and composition of gut microbiome of cervical cancer patients: Do results of 16S rRNA sequencing and whole genome sequencing approaches align?. J Microbiol Methods 185:106213, 2021. e-Pub 2021. PMID: 33785357.
Mitra A, Yoshida-Court K, Solley TN, Mikkelson M, Yeung CLA, Nick A, Lu K, Klopp AH. Extracellular Vesicles Derived from Ascitic Fluid Enhance Growth and Migration of Ovarian Cancer Cells. Sci Rep 11(1):9149, 2021. e-Pub 2021. PMID: 33911091.
Rigaud B, Anderson BM, Yu ZH, Gobeli M, Cazoulat G, Söderberg J, Samuelsson E, Lidberg D, Ward C, Taku N, Cardenas C, Rhee DJ, Venkatesan AM, Peterson CB, Court L, Svensson S, Löfman F, Klopp AH, Brock KK. Automatic Segmentation Using Deep Learning to Enable Online Dose Optimization During Adaptive Radiation Therapy of Cervical Cancer. Int J Radiat Oncol Biol Phys 109(4):1096-1110, 2021. e-Pub 2020. PMID: 33181248.
Small W, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. Int J Radiat Oncol Biol Phys 109(2):413-424, 2021. e-Pub 2020. PMID: 32905846.
Sims TT, El Alam MB, Karpinets TV, Dorta-Estremera S, Hegde VL, Nookala S, Yoshida-Court K, Wu X, Biegert GWG, Delgado Medrano AY, Solley T, Ahmed-Kaddar M, Chapman BV, Sastry KJ, Mezzari MP, Petrosino JF, Lin LL, Ramondetta L, Jhingran A, Schmeler KM, Ajami NJ, Wargo J, Colbert LE, Klopp AH. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Commun Biol 4(1):237, 2021. e-Pub 2021. PMID: 33619320.
Iwase T, Parikh A, Dibaj SS, Shen Y, Shrimanker TV, Chainitikun S, Kida K, Sapon ME, Sahin O, James A, Medrano AYD, Klopp AH, Ueno NT. The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy. Cancers (Basel) 13(4):1-11, 2021. e-Pub 2021. PMID: 33557032.
Sims, TT, Colbert, LE, Klopp, AH. The role of the cervicovaginal and gut microbiome in cervical intraepithelial neoplasia and cervical cancer. Journal of Immunotherapy and Precision Oncology 4(2):72-78, 2021. PMID: 35663536.
Armbruster SD, Fellman BM, Jhingran A, Eifel PJ, Klopp AH, Coleman RL, Ramondetta LM, Frumovitz M. A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation. Support Care Cancer 29(1):213-222, 2021. e-Pub 2020. PMID: 32338316.
Bahig H, Fuller CD, Mitra A, Yoshida-Court K, Solley T, Ping Ng S, Abu-Gheida I, Elgohari B, Delgado A, Rosenthal DI, Garden AS, Frank SJ, Reddy JP, Colbert L, Klopp AH. Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer. Clin Transl Radiat Oncol 26:98-103, 2021. e-Pub 2020. PMID: 33367119.
El Alam MB, Sims TT, Kouzy R, Biegert GWG, JABI J, Karpinets TV, Yoshida-Court K, Wu X, Delgado-Medrano AY, Mezzari MP, Ajami NJ, Solley T, Ahmed-Kaddar M, Lin LL, Ramondetta L, Jazaeri A, Jhingran A, Eifel PJ, Schmeler KM, Wargo J, Klopp AH, Colbert LE. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers. PLoS One 16(3):e0247905, 2021. e-Pub 2021. PMID: 33662003.
Kouzy R, Abi Jaoude J, Lin D, El Alam MB, Minsky BD, Koay EJ, Das P, Holliday EB, Klopp AH, Colbert LE, Taniguchi CM. Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern Chemoradiation. JCO Oncol Pract 16(12):e1524-e1531, 2020. e-Pub 2020. PMID: 32609585.
Karpinets TV, Solley TN, Mikkelson MD, Dorta-Estremera S, Nookala SS, Medrano AYD, Petrosino JF, Mezzari MP, Zhang J, Futreal PA, Sastry KJ, Colbert LE, Klopp AH. Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice. Cancer Prev Res (Phila) 13(12):997-1006, 2020. e-Pub 2020. PMID: 32917644.
Netherton TJ, Rhee DJ, Cardenas CE, Chung C, Klopp AH, Peterson CB, Howell RM, Balter PA, Court LE. Evaluation of a multiview architecture for automatic vertebral labeling of palliative radiotherapy simulation CT images. Med Phys 47(11):5592-5608, 2020. e-Pub 2020. PMID: 33459402.
Chun SG, Klopp AH. Meeting the Burden of Proof to Justify Intensity-Modulated Radiation for Brain Metastases. J Clin Oncol 38(29):JCO2000486, 2020. e-Pub 2020. PMID: 32783671.
Shushkevich A, Thaker PH, Littell RD, Shah NA, Chiang S, Thornton K, Hensley ML, Slomovitz BM, Holcomb KM, Leitao MM, Toboni MD, Powell MA, Levine DA, Dowdy SC, Klopp AH, Brown J. State of the science: Uterine sarcomas: From pathology to practice. Gynecol Oncol 159(1):3-7, 2020. e-Pub 2020. PMID: 32839026.
Klopp AH. Introduction: Cervical Cancer. Semin Radiat Oncol 30(4):263-264, 2020. PMID: 32828381.
Sims TT, Colbert LE, Klopp AH. The role of the cervicovaginal and gut microbiome in HPV-associated gynecologic malignancies. J Immunol Res 3(4):1-7, 2020. PMID: None.
Sims TT, Biegert GWG, Ramogola-Masire D, Ngoni K, Solley T, Ning MS, El Alam MB, Mezzari M, Petrosino J, Zetola NM, Schmeler KM, Colbert LE, Klopp AH, Grover S. Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancer. Int J Gynecol Cancer 30(8):1151-1156, 2020. e-Pub 2020. PMID: 32675252.
Elledge CR, Beriwal S, Chargari C, Chopra S, Erickson BA, Gaffney DK, Jhingran A, Klopp AH, Small W, Yashar CM, Viswanathan AN. Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations. Gynecol Oncol 158(2):244-253, 2020. e-Pub 2020. PMID: 32563593.
Ning MS, Venkatesan AM, Stafford RJ, Bui TP, Carlson R, Bailard NS, Vedam S, Davis R, Olivieri ND, Guzman AB, Incalcaterra JR, McKelvey FA, Thaker NG, Rauch GM, Tang C, Frank SJ, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis. Brachytherapy 19(4):427-437, 2020. e-Pub 2019. PMID: 31786169.
Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp AH, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, Ning MS, Robinson IJ, Rosenthal DI, Shah SJ, Woodward WA, Zaebst DJ, Dabaja BS, Das P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Adv Radiat Oncol 5(4):567-572, 2020. e-Pub 2020. PMID: 32775771.
Ning MS, McAleer MF, Jeter MD, Minsky BD, Ghafar RA, Robinson IJ, Nitsch PL, Zaebst DJ, Todd SE, Nguyen J, Lin SH, Liao Z, Lee P, Gunn GB, Klopp AH, Dabaja BS, Nguyen QN, Chronowski GM, Bloom ES, Koong AC, Das P. Mitigating the impact of COVID-19 on oncology: Clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19. Radiother Oncol 148:252-257, 2020. e-Pub 2020. PMID: 32474129.
Lin D, Kouzy R, Abi Jaoude J, Noticewala SS, Delgado Medrano AY, Klopp AH, Taniguchi CM, Colbert LE. Microbiome factors in HPV-driven carcinogenesis and cancers. PLoS Pathog 16(6):e1008524, 2020. e-Pub 2020. PMID: 32497113.
Salcedo MP, Sood AK, Jhingran A, Eifel PJ, Klopp AH, Iyer RB, Fellman BM, Jimenez C, Schmeler KM. Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women. Cancer 126(11):2607-2613, 2020. e-Pub 2020. PMID: 32125711.
Ning MS, Vedam S, Ma J, Stafford RJ, Bruno TL, Cunningham M, Starks C, Lawyer A, Venkatesan AM, Wang L, Wang J, Olivieri ND, Guzman AB, Incalcaterra JR, Thaker NG, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignancies. Brachytherapy 19(3):305-315, 2020. e-Pub 2020. PMID: 32265119.
Yeung AR, Pugh SL, Klopp AH, Gil KM, Wenzel L, Westin SN, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Bruner DW, Kachnic LA. Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study. J Clin Oncol 38(15):JCO1902381, 2020. e-Pub 2020. PMID: 32073955.
Mitra A, Grossman Biegert GW, Delgado AY, Karpinets TV, Solley TN, Mezzari MP, Yoshida-Court K, Petrosino JF, Mikkelson MD, Lin L, Eifel P, Zhang J, Ramondetta LM, Jhingran A, Sims TT, Schmeler K, Okhuysen P, Colbert LE, Klopp AH. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys 107(1):163-171, 2020. e-Pub 2020. PMID: 31987960.
Rigaud B, Cazoulat G, Vedam S, Venkatesan AM, Peterson CB, Taku N, Klopp AH, Brock KK. Modeling Complex Deformations of the Sigmoid Colon Between External Beam Radiation Therapy and Brachytherapy Images of Cervical Cancer. Int J Radiat Oncol Biol Phys 106(5):1084-1094, 2020. e-Pub 2020. PMID: 32029345.
Sapienza LG, Salcedo MP, Ning MS, Jhingran A, Klopp AH, Calsavara VF, Schmeler KM, Leite Gomes MJ, de Freitas Carvalho E, Baiocchi G. Pelvic Insufficiency Fractures After External Beam Radiation Therapy for Gynecologic Cancers: A Meta-analysis and Meta-regression of 3929 Patients. Int J Radiat Oncol Biol Phys 106(3):475-484, 2020. e-Pub 2019. PMID: 31580930.
Sims TT, Colbert LE, Zheng J, Delgado Medrano AY, Hoffman KL, Ramondetta L, Jazaeri A, Jhingran A, Schmeler KM, Daniel CR, Klopp A. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls. Gynecol Oncol 155(2):237-244, 2019. e-Pub 2019. PMID: 31500892.
Klopp AH, Eifel PJ. IMRT all the way. Int J Radiat Oncol Biol Phys 105(4):692-693, 2019. PMID: 31655653.
Lu DJ, Luu M, Yashar CM, Klopp AH, Kamrava M. An evaluation of gender diversity in the American Brachytherapy Society. Brachytherapy 18(6):835-840, 2019. e-Pub 2019. PMID: 31402211.
Netherton T, Li Y, Gao S, Klopp A, Balter P, Court LE, Scheuermann R, Kennedy C, Dong L, Metz J, Mihailidis D, Ling C, Lee MY, Constantin M, Thompson S, Kauppinen J, Uusitalo P. Experience in commissioning The Halcyon linac. Med Phys 46(10):4304-4313, 2019. e-Pub 2019. PMID: 31310678.
Singer L, Braunstein S, Klopp A, Joyner M. Development and Implementation of a Simulation-Based Educational Workshop on Gynecological Brachytherapy: Pilot Study at a National Meeting. Pract Radiat Oncol 9(5):e465-e472, 2019. e-Pub 2019. PMID: 31128303.
Sapienza LG, Ning MS, Pellizzon ACA, Jhingran A, Klopp AH, Lin LL, Kollmeier MA, Calsavara VF, Gutierrez NDS, Chojniak R, Gomes MJL, Baiocchi G. Detection of air gaps around the cylinder by postinsertion computed tomography in vaginal cuff brachytherapy: A prospective series, systematic review, and meta-analysis. Brachytherapy 18(5):620-626, 2019. e-Pub 2019. PMID: 31160198.
Venkatesan AM, Menias CO, Jones KM, Rauch GM, Stafford RJ, Klopp AH. MRI for Radiation Therapy Planning in Human Papillomavirus-associated Gynecologic Cancers. Radiographics 39(5):1476-1500, 2019. PMID: 31498740.
Coletta AM, Klopp AH, Fogelman D, Parikh AM, Li Y, Garg N, Basen-Engquist K. Dual-Energy X-Ray Absorptiometry Compared to Computed Tomography for Visceral Adiposity Assessment Among Gastrointestinal and Pancreatic Cancer Survivors. Sci Rep 9(1):11500, 2019. e-Pub 2019. PMID: 31395928.
Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko SM, Pezzi TA, Boyce-Fappiano DR, Shaitelman SF, Frank SJ, Thaker NG. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing. Brachytherapy 18(4):445-452, 2019. e-Pub 2019. PMID: 30992185.
Chapman BV, Swanick CW, Ning MS, Allen PK, Soliman PT, Westin SN, Pardeshi V, Broaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer. Gynecol Oncol 154(1):22-28, 2019. e-Pub 2019. PMID: 31109659.
Gil KM, Pugh SL, Klopp AH, Yeung AR, Wenzel L, Westin SN, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Kachnic LA, Bruner DW. Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy. Gynecol Oncol 154(1):183-188, 2019. e-Pub 2019. PMID: 31104905.
Vorbeck CS, Jhingran A, Iyer RB, Loft A, Klopp A, Mirza MR, Sobremonte A, Vedam S, Vogelius IR. Patterns of treatment failure in patients undergoing adjuvant or definitive radiotherapy for vulvar cancer. Int J Gynecol Cancer 29(5):857-862, 2019. e-Pub 2019. PMID: 31126968.
Ho JC, Fang P, Cardenas CE, Mohamed ASR, Fuller CD, Allen PK, Bhosale PR, Frumovitz MM, Jhingran A, Klopp AH. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer. Radiother Oncol 135:58-64, 2019. e-Pub 2019. PMID: 31015171.
Rigaud B, Klopp A, Vedam S, Venkatesan A, Taku N, Simon A, Haigron P, de Crevoisier R, Brock KK, Cazoulat G. Deformable image registration for dose mapping between external beam radiotherapy and brachytherapy images of cervical cancer. Phys Med Biol 64(11):115023, 2019. e-Pub 2019. PMID: 30913542.
Suidan RS, He W, Sun CC, Zhao H, Smith GL, Klopp AH, Fleming ND, Lu KH, Giordano SH, Meyer LA. National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer. Gynecol Oncol 152(3):439-444, 2019. PMID: 30876486.
Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, Carchman E, Cohen A, Crysler OV, Gupta N, Gustafson C, Hall A, Johung KL, Klopp A, LaCasce AS, Lin C, Mehta A, Menon MP, Morgan D, Nathwani N, Noy A, Ratner L, Rizza S, Rudek MA, Sanchez J, Taylor J, Tomlinson B, Wang CJ, Yendamuri S, Dwyer MA, CGC, Freedman-Cass DA. AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 17(2):171-189, 2019. PMID: 30787130.
Kurnit KC, Previs RA, Soliman PT, Westin SN, Klopp AH, Fellman BM, Lu KH, Ramondetta LM, Fleming ND. Prognostic factors impacting survival in early stage uterine carcinosarcoma. Gynecol Oncol 152(1):31-37, 2019. e-Pub 2018. PMID: 30414738.
Dorta-Estremera S, Colbert LE, Nookala SS, Yanamandra AV, Yang G, Delgado A, Mikkelson M, Eifel P, Jhingran A, Lilie LL, Welsh J, Schmeler K, Sastry JK, Klopp A. Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer. Int J Radiat Oncol Biol Phys 102(3):593-600, 2018. e-Pub 2018. PMID: 30017792.
Albuquerque K, Chino J, Klopp A, Kamrava M, Beriwal S. Defining the Place of Adjuvant Chemotherapy and Radiation for High-Risk Endometrial Cancer From Recent Randomized Clinical Trials: Some Answers, More Questions. Int J Radiat Oncol Biol Phys 102(3):473-477, 2018. PMID: 30238893.
Azad MB, Vehling L, Chan D, Klopp A, Nickel NC, McGavock JM, Becker AB, Mandhane PJ, Turvey SE, Moraes TJ, Taylor MS, Lefebvre DL, Sears MR, Subbarao P, Investigators CS. Infant Feeding and Weight Gain: Separating Breast Milk From Breastfeeding and Formula From Food. Pediatrics 142(4), 2018. PMID: 30249624.
Li Y, Netherton T, Nitsch PL, Gao S, Klopp AH, Balter PA, Court LE. Independent validation of machine performance check for the Halcyon and TrueBeam linacs for daily quality assurance. J Appl Clin Med Phys 19(5):375-382, 2018. e-Pub 2018. PMID: 30016578.
Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, Carchman E, Cohen A, Gupta N, Johung KL, Klopp A, LaCasce AS, Lin C, Makarova-Rusher OV, Mehta A, Menon MP, Morgan D, Nathwani N, Noy A, Palella F, Ratner L, Rizza S, Rudek MA, Taylor J, Tomlinson B, Wang CJ, Dwyer MA, Freedman-Cass DA. Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16(8):986-1017, 2018. PMID: 30099375.
Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. J Clin Oncol 36(24):JCO2017774273, 2018. e-Pub 2018. PMID: 29989857.
Netherton T, Li Y, Nitsch P, Shaitelman S, Balter P, Gao S, Klopp A, Muruganandham M, Court L. Interplay effect on a 6-MV flattening-filter-free linear accelerator with high dose rate and fast multi-leaf collimator motion treating breast and lung phantoms. Med Phys 45(6):2369-2376, 2018. e-Pub 2018. PMID: 29611210.
Li Y, Netherton T, Nitsch PL, Balter PA, Gao S, Klopp AH, Court LE. Normal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT. J Appl Clin Med Phys 19(3):52-57, 2018. e-Pub 2018. PMID: 29500856.
Omelchenko N, Saban KL, Andresen P, Klopp A, Lau J. Empowered to Serve: Implementing Community Stroke Outreach Using Peer Educators to Improve Readiness to Act Among Local Community Members. J Neurosci Nurs 50(2):111-115, 2018. PMID: 29521736.
Stecklein SR, Frumovitz M, Klopp AH, Gunther JR, Eifel PJ. Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy. Gynecol Oncol 148(3):474-479, 2018. e-Pub 2018. PMID: 29336837.
Klopp AH. Radiation Is the Place to Start. Int J Radiat Oncol Biol Phys 100(2):289, 2018. PMID: 29353645.
Zhang Y, Coletta AM, Allen PK, Parikh AM, Cox-Mattin M, Meyer LA, Sun CC, Basen-Engquist KM, Lu KH, Klopp AH. Perirenal Adiposity is Associated With Lower Progression-Free Survival From Ovarian Cancer. Int J Gynecol Cancer 28(2):285-292, 2018. PMID: 29303933.
Gunther JR, Christensen EN, Allen PK, Ramondetta LM, Jhingran A, Fleming ND, Euscher ED, Lu KH, Eifel PJ, Klopp AH. Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma. Int J Gynecol Cancer 28(1):114-121, 2018. e-Pub 2017. PMID: 28930812.
Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol 148(1):132-138, 2018. e-Pub 2017. PMID: 29089122.
Klopp A, Vehling L, Becker AB, Subbarao P, Mandhane PJ, Turvey SE, Lefebvre DL, Sears MR, Investigators CS, Azad MB. Modes of Infant Feeding and the Risk of Childhood Asthma: A Prospective Birth Cohort Study. J Pediatr 190:192-199.e2, 2017. PMID: 29144244.
Glaser S, Mahantshetty U, Lee L, Klopp A, Beriwal S. Genomics and 3-Dimensional Brachytherapy for Cervical Cancer: Significant Steps Forward. Int J Radiat Oncol Biol Phys 99(3):505-509, 2017. PMID: 29280437.
Kamrava M, Beriwal S, Erickson B, Gaffney D, Jhingran A, Klopp AH, Park SJ, Viswanathan A, Yashar C, Lin L. American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature. Brachytherapy 16(6):1129-1143, 2017. e-Pub 2017. PMID: 28888417.
Orio, PF, Yashar, CM, Petereit, DG, Mourtada, F, Klopp, AH, Gaffney, DK, Frank, SJ. 2017 American Brachytherapy Society's Annual Meeting Report. Translational Andrology and Urology 6(5):1005-1013, 2017. PMID: None.
Holman LL, Pal N, Iglesias DA, Soliman PT, Balakrishnan N, Klopp A, Broaddus RR, Fleming ND, Munsell MF, Lu KH, Westin SN. Factors prognostic of survival in advanced-stage uterine serous carcinoma. Gynecol Oncol 146(1):27-33, 2017. e-Pub 2017. PMID: 28465008.
Osborne EM, Klopp AH, Jhingran A, Meyer LA, Eifel PJ. Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy. Pract Radiat Oncol 7(3):e165-e173, 2017. e-Pub 2016. PMID: 27743802.
Swanick CW, Eifel PJ, Klopp AH. In Reply to Mazeron et al. Int J Radiat Oncol Biol Phys 97(3):639, 2017. PMID: 28126311.
Ho JC, Allen PK, Bhosale PR, Rauch GM, Fuller CD, Mohamed AS, Frumovitz M, Jhingran A, Klopp AH. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. Int J Radiat Oncol Biol Phys 97(3):546-553, 2017. e-Pub 2016. PMID: 28011045.
Parikh AM, Coletta AM, Yu ZH, Rauch GM, Cheung JP, Court LE, Klopp AH. Development and validation of a rapid and robust method to determine visceral adipose tissue volume using computed tomography images. PLoS One 12(8):e0183515, 2017. e-Pub 2017. PMID: 28859115.
Swanick CW, Castle KO, Vedam S, Munsell MF, Turner LM, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer. Int J Radiat Oncol Biol Phys 96(4):793-800, 2016. e-Pub 2016. PMID: 27788952.
Yashar CM, Beriwal S, Klopp AH, Mell L. Progress in Vulvar and Endometrial Cancers: Exploiting Anatomy and Biology and Improving Systemic Therapy. Int J Radiat Oncol Biol Phys 96(1):1-5, 2016. PMID: 27511840.
Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp AH, Koh WJ, Lim K, Petersen I, Portelance L, Small W, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W. Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. Int J Radiat Oncol Biol Phys 95(4):1191-1200, 2016. e-Pub 2016. PMID: 27130794.
Jhingran A, Klopp AH. Big Data to the Rescue: Is there a benefit to combined-modality adjuvant therapy in endometrial cancer?. Gynecol Oncol 141(3):403-4, 2016. PMID: 27210265.
Stecklein SR, Jhingran A, Burzawa J, Ramalingam P, Klopp AH, Eifel PJ, Frumovitz M. Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecol Oncol 143(3):552-557, 2016. e-Pub 2016. PMID: 27645621.
Grant SR, Walker GV, Koshy M, Shaitelman SF, Klopp AH, Frank SJ, Pugh TJ, Allen PK, Mahmood U. Impact of Insurance Status on Radiation Treatment Modality Selection Among Potential Candidates for Prostate, Breast, or Gynecologic Brachytherapy. Int J Radiat Oncol Biol Phys 93(5):968-75, 2015. e-Pub 2015. PMID: 26452570.
Fleming ND, Soliman PT, Westin SN, Reis RD, Munsell M, Klopp AH, Frumovitz M, Nick AM, Schmeler K, Ramirez PT. Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer. Int J Gynecol Cancer 25(8):1437-44, 2015. e-Pub 2015. PMID: 26332387.
Ho JC, Allen PK, Jhingran A, Westin SN, Lu KH, Eifel PJ, Klopp AH. Management of nodal recurrences of endometrial cancer with IMRT. Gynecol Oncol 139(1):40-6, 2015. e-Pub 2015. PMID: 26193429.
Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, Gaffney D, Jones E, Klopp AH, Small W, Thomadsen B, Yashar C, Viswanathan A. Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. Brachytherapy 14(5):587-99, 2015. e-Pub 2015. PMID: 26186975.
Gardner CS, Sunil J, Klopp AH, Devine CE, Sagebiel T, Viswanathan C, Bhosale PR. Primary vaginal cancer: role of MRI in diagnosis, staging and treatment. Br J Radiol 88(1052):20150033, 2015. e-Pub 2015. PMID: 25966291.
Grant JD, Garg AK, Gopal R, Soliman PT, Jhingran A, Eifel PJ, Klopp AH. Isolated Port-Site Metastases After Minimally Invasive Hysterectomy for Endometrial Cancer: Outcomes of Patients Treated With Radiotherapy. Int J Gynecol Cancer 25(5):869-74, 2015. e-Pub 2015. PMID: 25790043.
Swanick CW, Castle KO, Rechner LA, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical cancer. Brachytherapy 14(3):385-9, 2015. e-Pub 2015. PMID: 25620163.
Yashar C, Beriwal S, Mell L, Klopp AH. A blast from the past and foresight for the future of gynecologic oncology. Int J Radiat Oncol Biol Phys 91(5):885-7, 2015. PMID: 25832680.
Thaker NG, Klopp AH, Jhingran A, Frumovitz M, Iyer RB, Eifel PJ. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: Time to reconsider the FIGO staging system?. Gynecol Oncol 136(2):269-73, 2015. e-Pub 2014. PMID: 25524458.
Bishop AJ, Allen PK, Klopp AH, Meyer LA, Eifel PJ. Relationship Between Low Hemoglobin Levels and Outcomes After Treatment With Radiation or Chemoradiation in Patients With Cervical Cancer: Has the Impact of Anemia Been Overstated?. Int J Radiat Oncol Biol Phys 91(1):196-205, 2015. e-Pub 2014. PMID: 25446609.
Salimian Rizi B, Caneba C, Nowicka A, Nabiyar AW, Liu X, Chen K, Klopp AH, Nagrath D. Nitric oxide mediates metabolic coupling of omentum-derived adipose stroma to ovarian and endometrial cancer cells. Cancer Res 75(2):456-71, 2015. e-Pub 2014. PMID: 25425006.
Zhang Y, Nowicka A, Solley TN, Wei C, Parikh A, Court L, Burks JK, Andreeff M, Woodward WA, Dadbin A, Kolonin MG, Lu KH, Klopp AH. Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers. PLoS One 10(8):e0136361, 2015. e-Pub 2015. PMID: 26317219.
Lacerda L, Debeb BG, Smith D, Larson R, Solley T, Xu W, Krishnamurthy S, Gong Y, Levy LB, Buchholz T, Ueno NT, Klopp AH, Woodward WA. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model. Breast Cancer Res 17(1):42, 2015. e-Pub 2015. PMID: 25887413.
Carroll A, Ramirez PT, Westin SN, Soliman PT, Munsell MF, Nick AM, Schmeler KM, Klopp AH, Fleming ND. Uterine adenosarcoma: An analysis on management, outcomes, and risk factors for recurrence. Gynecol Oncol 135(3):455-61, 2014. e-Pub 2014. PMID: 25449308.
Frumovitz M, Jhingran A, Soliman PT, Klopp AH, Schmeler KM, Eifel PJ. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol 124(6):1098-104, 2014. PMID: 25415160.
Rauch GM, Kaur H, Choi H, Ernst RD, Klopp AH, Boonsirikamchai P, Westin SN, Marcal LP. Optimization of MR Imaging for Pretreatment Evaluation of Patients with Endometrial and Cervical Cancer. Radiographics 34(4):1082-98, 2014. PMID: 25019443.
Skinner HD, Sturgis EM, Klopp AH, Ang KK, Rosenthal DI, Garden AS, Morrison WH, Gunn GB, Beadle BM. Clinical characteristics of patients with multiple potentially HPV-related malignancies. Head Neck 36(6):819-25, 2014. e-Pub 2013. PMID: 23720126.
Klopp AH, Smith BD, Alektiar K, Cabrera A, Damato AL, Erickson B, Fleming G, Gaffney D, Greven K, Lu K, Miller D, Moore D, Petereit D, Schefter T, Small W, Yashar C, Viswanathan AN. The role of postoperative radiation therapy for endometrial cancer: Executive Summary of an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 4(3):137-44, 2014. e-Pub 2014. PMID: 24766678.
Christensen EN, Yu HZ, Klopp AH, Tsai JC, Lawyer AA, Court LE, Eifel PJ. Variable impact of intracavitary brachytherapy fractionation schedule on biologically effective dose to organs at risk in patients with cervical cancer. Brachytherapy 13(3):240-9, 2014. e-Pub 2013. PMID: 24188993.
Verma J, Sulman EP, Jhingran A, Tucker SL, Rauch GM, Eifel PJ, Klopp AH. Dosimetric Predictors of Duodenal Toxicity After Intensity Modulated Radiation Therapy for Treatment of the Para-aortic Nodes in Gynecologic Cancer. Int J Radiat Oncol Biol Phys 88(2):357-62, 2014. PMID: 24411609.
Tsai CJ, Sulman EP, Eifel PJ, Jhingran A, Allen PK, Deavers MT, Klopp AH. Galectin-7 Levels Predict Radiation Response in Squamous Cell Carcinoma of the Cervix. Gynecol Oncol 131(3):645-9, 2013. e-Pub 2013. PMID: 23643871.
Mikell JK, Klopp AH, Price M, Mourtada F. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats. Brachytherapy 12(6):645-653, 2013. e-Pub 2013. PMID: 23891341.
Spaeth EL, Labaff AM, Toole BP, Klopp AH, Andreeff M, Marini FC. Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment. Cancer Res 73(17):5347-59, 2013. e-Pub 2013. PMID: 23838935.
Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-field radiation therapy for locoregionally recurrent ovarian cancer. Gynecol Oncol 130(2):300-5, 2013. e-Pub 2013. PMID: 23648467.
Yu, ZH, Yang, JN, Dong, L, Zhang, Y, Court, LE, Mourtada, F, Tucker, SL, Klopp, AH, Eifel, PJ, Kudchadker, RJ. Voxel‐By‐Voxel Validation of Deformable Image Registration Between External Beam and Intracavitary Brachytherapy Images Using Artificial CT Images Created From Patient Populations. Medical physics 40(6):90, 2013. PMID: None.
Klopp AH, Moughan J, Portelance L, Miller BE, Salehpour MR, Hildebrandt E, Nuanjing J, D'Souza D, Souhami L, Small W, Gaur R, Jhingran A. Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer. Int J Radiat Oncol Biol Phys 86(1):83-90, 2013. PMID: 23582248.
Klopp AH, Mourtada F, Yu ZH, Beadle BM, Munsell MF, Jhingran A, Eifel PJ. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer. Pract Radiat Oncol 3(2):115-123, 2013. e-Pub 2012. PMID: 24674314.
Takiar V, Fontanilla HP, Eifel PJ, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Klopp AH. Anatomic Distribution of Fluorodeoxyglucose-Avid Para-aortic Lymph Nodes in Patients With Cervical Cancer. Int J Radiat Oncol Biol Phys 85(4):1045-50, 2013. e-Pub 2013. PMID: 23332221.
Fontanilla HP, Klopp AH, Lindberg ME, Jhingran A, Kelly P, Takiar V, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of [18F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Pract Radiat Oncol 3(1):45-53, 2013. e-Pub 2012. PMID: 24674263.
Shirvani SM, Klopp AH, Likhacheva A, Jhingran A, Soliman PT, Lu KH, Eifel PJ. Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. Pract Radiat Oncol 3(1):e21-8, 2013. e-Pub 2012. PMID: 24674269.
Xu W, Lacerda L, Debeb BG, Atkinson RL, Solley TN, Li L, Orton D, McMurray JS, Hang BI, Lee E, Klopp AH, Ueno NT, Reuben JM, Krishnamurthy S, Woodward WA. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer. PLoS One 8(8):e71508, 2013. e-Pub 2013. PMID: 24013655.
Nowicka A, Marini FC, Solley TN, Elizondo PB, Zhang Y, Sharp HJ, Broaddus R, Kolonin M, Mok SC, Thompson MS, Woodward WA, Lu K, Salimian B, Nagrath D, Klopp AH. Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration and chemoresistance. PLoS One 8(12):e81859, 2013. e-Pub 2013. PMID: 24312594.
Frumovitz M, Ramirez PT, Macapinlac HA, Klopp AH, Nick AM, Ramondetta LM, Jhingran A. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: Implications for surgical staging. Int J Gynecol Cancer 22(7):1203-7, 2012. e-Pub 2012. PMID: 22810967.
Mikell JK, Klopp AH, Gonzalez GM, Kisling KD, Price MJ, Berner PA, Eifel PJ, Mourtada F. Impact of heterogeneity-based dose calculation using a deterministic grid-based boltzmann equation solver for intracavitary brachytherapy. Int J Radiat Oncol Biol Phys 83(3):e417-22, 2012. e-Pub 2012. PMID: 22436788.
Mikell, JK, Klopp, AH, Price, MJ, Mourtada, F. Impact of Model Based Dose Calculation Algorithm for Ir‐192 Intracavitary Brachytherapy with Shielded Applicator. Medical physics 39(6):3802, 2012. PMID: 28517225.
Yu, ZH, Klopp, AH, Kudchadker, RJ, Mourtada, F, Eifel, PJ, Park, PC, Dong, L. A Universal Margin Reconstruction Method for Estimating Anatomy Induced Proton Range Uncertainties. Medical physics 39(6):3904, 2012. PMID: None.
Kidd, S, Spaeth, E, Watson, K, Burks, JK, Lu, H, Klopp, AH, Andreeff, M, Marini, F. Origins of the tumor microenvironment. PloS one 7(2), 2012. PMID: 22363446.
Klopp AH, Zhang Y, Solley T, Amaya-Manzanares F, Marini F, Andreeff M, Debeb B, Woodward W, Schmandt R, Broaddus R, Lu K, Kolonin MG. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin Cancer Res 18(3):771-82, 2012. e-Pub 2011. PMID: 22167410.
Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp AH, Andreeff M, Marini FC. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One 7(2):e30563, 2012. e-Pub 2012. PMID: None.
Klopp AH, Eifel PJ. Chemoradiotherapy for cervical cancer in 2010. Curr Oncol Rep 13(1):77-85, 2011. e-Pub 2010. PMID: 21042887.
Turner LM, Howard JA, Dehghanpour P, Barrett RD, Rebueno N, Palmer M, Vedam S, Klopp AH, Komaki R, Welsh JW. Exploring the feasibility of dose escalation positron emission tomography-positive disease with intensity-modulated radiation therapy and the effects on normal tissue structures for thoracic malignancies. Med Dosim 36(4):383-388, 2011. e-Pub 2010. PMID: 21144734.
Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F. Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?. Stem Cells 29(1):11-9, 2011. PMID: 21280155.
Garg AK, Jhingran A, Klopp AH, Aggarwal BB, Kunnumakkara AB, Broadus RR, Eifel PJ, Buchholz TA. Expression of nuclear transcription factor Kappa B in locally advanced human cervical cancer treated with definitive chemoradiation. Int J Radiat Oncol Biol Phys 78(5):1331-6, 2010. e-Pub 2010. PMID: 20231067.
Clements A, Euscher E, Lacour R, Merritt W, Klopp AH, Ramondetta L. The presence of human papillomavirus or p16 in six cases of retroperitoneal carcinoma. Obstet Gynecol 116(5):1042-6, 2010. PMID: 20966687.
Mikell, JK, Klopp, AH, Kisling, K, Berner, P, Price, MJ, Mourtada, F. Grid‐Based Boltzmann Solver (GBBS) vs TG‐43 for Ir‐192 HDR Intracavitary Brachytherapy: A Retrospective Dosimetric Study. Medical physics 37(6):3192, 2010. PMID: None.
Yu, ZH, Richardson, S, Zhang, Y, Klopp, AH, Dong, L, Mourtada, F. Using MRI‐Based Deformable Image Registration to Accumulate 3D Total Dose Distribution from Intracavitary Brachytherapy Fractions of Cervical Cancer. Medical physics 37(6):3392, 2010. PMID: None.
Klopp AH, Lacerda L, Gupta A, Debeb BG, Solley T, Li L, Spaeth E, Xu W, Zhang X, Lewis MT, Reuben JM, Krishnamurthy S, Ferrari M, Gaspar R, Buchholz TA, Cristofanilli M, Marini F, Andreeff M, Woodward WA. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One 5(8):e12180, 2010. e-Pub 2010. PMID: 20808935.
Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp AH, Battula VL, Weil M, Andreeff M, Marini FC. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27(10):2614-23, 2009. PMID: 19650040.
Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ. Node-positive adenocarcinoma of the endometrium: Outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol 115(1):6-11, 2009. e-Pub 2009. PMID: 19632709.
Yu, ZH, Balter, PA, Zhang, Y, Klopp, AH, Price, MJ, Eifel, PJ, Mourtada, F. Quantification of CT Artifact Reduction of Second Generation Intracavitary Brachytherapy Applicator. Medical physics 36(6):2531, 2009. PMID: None.
Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp AH, Hall B, Andreeff M, Marini F. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4(4):e4992, 2009. e-Pub 2009. PMID: 19352430.
Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiat Oncol 4:5, 2009. PMID: 19183471.
Klopp AH, Jhingran A, Ramdas L, Story MD, Broadus RR, Lu KH, Eifel PJ, Buchholz TA. Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome. Int J Radiat Oncol Biol Phys 71(1):226-36, 2008. PMID: 18406887.
Kidd S, Spaeth E, Klopp AH, Andreeff M, Hall B, Marini FC. The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy 10(7):657-67, 2008. PMID: 18985472.
Klopp AH, Chang JY, Tucker SL, Sulman EP, Balter PA, Liu HH, Bucci MK, Macapinlac HA, Komaki R, Cox JD. Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation. Int J Radiat Oncol Biol Phys 69(5):1409-16, 2007. PMID: 17904303.
Klopp AH, Spaeth EL, Dembinski JL, Woodward WA, Munshi A, Meyn RE, Cox JD, Andreeff M, Marini FC. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res 67(24):11687-95, 2007. PMID: 18089798.
Klopp AH, Eifel PJ. Gene expression profiling in cervical cancer: state of the art and future directions. Cancer J 12(3):170-4, 2006. PMID: 16803672.
Klopp, AH, Hendrickson, SB, Burns, WH. Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency. Journal of Virology 74(15):7016-7023, 2000. PMID: 10888640.
Glover, T, Klopp, AH, Miller, DE, Ascara-Wilke, JE, Adam, AN, Dagenais, SL, Wilke, CM, Dierick, HA, Beer, DG. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region. Cancer Research 58(15):3409-3414, 1998. PMID: 9699673.
Paradee, W, Wilke, CM, Wang, L, Shridhar, R, Mullins, CM, Klopp, AH, Glover, T, Smith, DI. A 350-kb cosmid contig in 3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints. Genomics 35(1):87-93, 1996. PMID: 8661108.
Wilke, CM, Hall, BK, Klopp, AH, Paradee, W, Smith, DI, Glover, T. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site. Human molecular genetics 5(2):187-195, 1996. PMID: 8824874.

Invited Articles

Klopp AH, Eifel PJ. Biological predictors of cervical cancer response to radiation therapy. Semin Radiat Oncol 22(2):143-150, 2012. PMID: 22385921.
Klopp AH, Woodward WA. Therapeutic strategies to eliminate breast cancer stem cells. Current Breast Cancer Reports 1:222-228, 2009. PMID: None.

Editorials

Jhingran A, Klopp AH. Big Data to the Rescue: Is there a benefit to combined-modality adjuvant therapy in endometrial cancer?. Gynecol Oncol 141(3):403-404, 2016. PMID: 27210265.

Abstracts

Konski AA, Deshmukh S, Klopp AH, Yeung AR, Westin SN, Thomson JS, Doncals DE, Cantuaria GHC, D'Souza DP, Chang A, Kundapur V, Mohan DS, Haas M, Kim YB, Ferguson CL, Pugh A, Kachnic LA. Quality-Adjusted Survival in Women with Gynecologic Malignancies Receiving IMRT after Surgery: A Patient Reported Outcome Study of RTOG 1203. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 102(3):S157-S158, 2018. PMID: None.
Chapman BV, Swanick CW, Allen PK, Soliman PT, Westin ST, Boaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH. Survival Outcomes of Stage IIIC Endometrioid and Non-Endometrioid Endometrial Cancer Treated with Combined Modality Adjuvant Therapy. International Journal of Radiation Oncology Biology Physics 102(3):E646-E646, 2018. PMID: None.
Colbert LE, Medrano AYD, Mikkelson MD, Previs R, Eifel PJ, Jhingran A, Ramondetta L, Futreal PA, Jazaeri A, Frumovitz M, Schmeler K, Hillman RT, Mathew G, Hutchinson DL, Ajami N, Stecklein SR, Okhuysen P, Petrosino J, Hahn SM, Klopp AH. Clonal Expansion of Antigen Specific T-Cells during Radiation Therapy for HPV Associated Cervical Cancers Is Regulated By the Vaginal Microbiome. International Journal of Radiation Oncology Biology Physics 102(3):S24-S24, 2018. PMID: None.
Netherton T, Li Y, Nitsch PL, Gao S, Muruganandham M, Shaitelman SF, Frank SJ, Hanh SM, Balter P, Klopp AH, Court LE. Efficiency and Efficacy of Intensity Modulated Treatments on a Novel Linear Accelerator. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 99(2):E703-E703, 2017. PMID: None.
Medrano AYD, Colbert LE, Hutchinson DL, Ajami N, Petrosino J, Mikkelson MD, Eifel PJ, Ramondetta L, Jhingran A, Hahn SM, Schmeler K, Okhuysen P, Klopp AH. Increased Diversity of the Intestinal Microbiome Predicts for Lower Rates of Patient Reported Acute Gastrointestinal Toxicity in Women Receiving Radiation Therapy for Cervical Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 99(2):S111-S112, 2017. PMID: None.
Colbert LE, Previs R, Medrano AYD, Eifel PJ, Jhingran A, Ramondetta L, Hahn SM, Jazaeri A, Frumovitz M, Schmeler K, Hutchinson DL, Ajami N, Petrosino J, Okhuysen P, Klopp AH. Rectal Microbiome Diversity Predicts Disease Response at Completion of Radiation Therapy for Squamous Cell Carcinoma of the Cervix. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 99(2):S51-S51, 2017. PMID: None.
By:Ahobila V, Ning MS, Jhingran A, Frumovitz M, Schmeler K, Eifel PJ, Klopp AH. Outcomes and Patterns of Relapse Following Definitive Radiation Therapy for Treatment of Oligometastatic Cervical Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 99(2):S26-S27, 2017. PMID: None.
Aristophanous M, Cardenas CE, Ho JC, Lee JS, Court LE, Eifel PJ, Klopp AH, Jhingran A. Development of a Radiomics-Based Survival Prediction Model for Cervical Cancer Patients. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 96(2):S72-S72, 2016. PMID: None.
Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko B, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Bruner DW. A Phase III Randomized Trial Comparing Patient-Reported Toxicity and Quality of Life (QOL) During Pelvic Intensity Modulated Radiation Therapy as Compared to Conventional Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 96(2):S3-S3, 2016. PMID: None.
Barkati M, King B, Fortin I, Portelance L, Viswanathan AN, Fyles TW, Beriwal S, Alfieri J, Lim KS, Harkenrider MM, Small W, Jhingran A, Jolicoeur M, Gaffney DK. Intensity Modulated Radiation Therapy for Vulvar Carcinoma: Changes in Practice Over 5 Years. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 86(2):E295-E296, 2016. PMID: None.
Stecklein SR, Burzawa JK, Jhingran A, Klopp AH, Eifel PJ, Frumovitz M. Patterns of Failure and Survival in Neuroendocrine Carcinoma of the Cervix. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 96(2):E294-E294, 2016. PMID: None.
Gunther JR, Yang J, Bhosale P, Williamson RT, Klopp AH, Jhingran A, Eifel PJ. Anatomic Distribution of Inguinal Lymph Nodes in Patients With Vulvar Carcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 96(2):E288-E288, 2016. PMID: None.
Yeung AR, Pugh SL, Klopp AH, Gil KM, Wenzel L, Westin SN, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko B, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Kachnic LA. Clinicians Underreport Adverse Events in NRG Oncology's Radiation Therapy Oncology Group 1203: The Importance of Using Patient-Reported Outcomes in Oncology Clinical Trials. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 96(2):S125-S125, 2016. PMID: None.
Yashar CM, Peterson IA, Bosch WR, Albuquerque KV, Beriwal S, Chino JP, Erickson BA, Feddock J, Gaffney DK, Iyer R, Klopp AH, Kunos C, Mayadev JS, Portelance L, Viswanathan AN, Wolfson AH, Jhingran A, Mell LK. Computed Tomography Consensus Clinical Target Volume Contouring for Intensity Modulated Radiation Therapy in Intact Cervical Carcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 96(2):S13-S14, 2016. PMID: None.
Osborne EM, Klopp AH, Jhingran A, Meyer L, Eifel PJ. Definitive Extended-Field Radiation Therapy for Cervical Cancer Patients With Para-Aortic Lymph Node Metastases. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 93(3):S202-S203, 2015. PMID: None.
Ho JC, Allen PK, Bhosale P, Rauch GM, Fuller CD, Mohammed ASR, Frumovitz M, Jhingran A, Eifel PJ, Klopp AH. Functional Imaging Predictors of Outcome in Cervical Cancer Following Chemoradiation. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 93(3):E289-E289, 2015. PMID: None.
Swanick CW, Castle KO, Vedam S, Turner LM, Yang J, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Comparison of CT and MRI-Based Clinical Target Volume Contours at the Time of Brachytherapy for Cervical Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 93(3):E282-E282, 2015. PMID: None.
Swanick CW, Castle KO, Cunningham MG, Vedam S, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Impact of normal tissue motion on dose to critical structures during intracavitary brachytherapy. Int J Radiat Oncol Biol Phys 90(1S):S482, 2014. PMID: None.
Takiar V, Burks JK, Sulman EP, Ramondetta LM, Jhingran A, Deavers MT, Eifel PJ, Klopp AH. PD-1 levels correlate with lymph node positivity in patients with squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys 90(1S):S479, 2014. PMID: None.
Bishop AJ, Allen PK, Klopp AH, Meyer LA, Eifel PJ. Modern therapeutic outcomes for cervical cancer may not be influenced by anemia. Int J Radiat Oncol Biol Phys 90(1S):S92, 2014. PMID: None.
Koay EJ, Jhingran A, Klopp AH, Levenback CF, Eifel PJ. Factors associated with long-term survival in locally-advanced squamous cell carcinoma of the vulva treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 87(2S):S129, 2013. PMID: None.
Thaker N, Klopp AH, Jhingran A, Frumovitz M, Iyer RB, Eifel PJ. Survival outcomes for patients with pelvic lymph node-positive stage IVB vulvar cancer: Time to reconsider the FIGO staging system?. Int J Radiat Oncol Biol Phys 87(2S):S129, 2013. PMID: None.
Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-field radiation therapy for locoregionally confined ovarian cancer. Int J Radiat Oncol Biol Phys 84(3S):S96, 2012. PMID: None.
Klopp AH, Jhingran A, Juloori A, Perinjelil V, Broaddus R, Lu K, Eifel PJ. Management of node-positive endometrial cancer with multimodality adjuvant therapy. Int J Radiat Oncol Biol Phys 84(3S):S455, 2012. PMID: None.
Juloori A, Klopp A, Ramondetta L, Jhingran A, Euscher E, Fleming N, Lu KJ, Eifel PJ. Radiation therapy in the management of carcinosarcoma of the uterus. Int J Radiat Oncol Biol Phys 84(3S):S456, 2012. PMID: None.
Mikell J, Klopp A, Price M, Mourtada F. Impact of model based dose calculation algorithm for Ir-192 intracavitary brachytherapy with shielded applicator. Med Phys 39:3802, 2012. PMID: None.
Christensen E, Yu ZH, Klopp AH, Lawyer AA, Court LE. Personalization of fractionation schedule for cervical cancer brachytherapy using biologically effective dose and 3d treatment planning. Int J Radiat Oncol Biol Phys 84(3S):S439, 2012. PMID: None.
Koay EJ, Jhingran A, Klopp AH, Levenback CF, Eifel PJ. Definitive radiation therapy of locally advanced squamous cell carcinoma of the vulva: Factors associated with vulvar disease control. Int J Radiat Oncol Biol Phys 84(3S):S460, 2012. PMID: None.
Klopp AH, Jhingran A, Pardeshi V, Schmeler K, Bodurka D, Lu K, Eifel PJ. Chemoradiation therapy followed by adjuvant chemotherapy for management of stage IIIC2 endometrial cancer. Int J Radiat Oncol Biol Phys 81(2):S191, 2011. PMID: None.
Verma J, Klopp AH, Jhingran A, Hildebrandt E, Tucker S, Eifel PJ. Dosimetric predictors of duodenal toxicity following IMRT to para-aortic nodes. Int J Radiat Oncol Biol Phys 81(2):S473, 2011. PMID: None.
Fontanilla HP, Klopp AH, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Distribution of para-aortic lymph nodes in cervical cancer. Int J Radiat Oncol Biol Phys 81(2):S187, 2011. PMID: None.
Fisher CM, Klopp AH, Jhingran A, Vera R, Levenback C, Eifel PJ. Vaginal cancer outcomes using intensity modulated radiation therapyfor definitive treatment at UT MD Anderson Cancer Center. Int J Radiat Oncol Biol Phys 81(2):S480, 2011. PMID: None.
Klopp AH, Moughan J, Portelance L, Miller BE, Salehpour MR, Souza DD, Souhami L, Small W, Gaur R, Jhingran A. Hematologic toxicity on RTOG 0418: A Phase II study of post-operative IMRT for gynecologic Cancer. Int J Radiat Oncol Biol Phys 78(3, Supplement):S121, 2010. PMID: None.
Patel H, Klopp AH, Jhingran A, Lindberg ME, Iyer RB, Kelly P, Zhang Y, Dong L, Eifel PJ. Mapping location of PET positive lymph nodes in cervical cancer. Int J Radiat Oncol Biol Phys 78(3):S143, 2010. PMID: None.
Mikell J, Klopp A, Kisling K, Berner P, Price M, Mourtada F. Grid-based boltzmann solver (GBBS) vs TG-43 for Ir-192 HDR intracavitary brachytherapy: A retrospective dosimetric study. Med Phys 37:3192, 2010. PMID: None.
Klopp A, White L, Spaeth E, Gupta A, Watson K, Meyn R, Andreeff M, Marini F. Mesenchymal stem cells impact tumor response to radiation therapy. AACR Meeting Abstracts:3955, 2009. PMID: None.
Sulman EP, Eifel PJ, Jhingran A, Aldape KD, Deavers MT, Klopp AH. Podoplanin expression is prognostic for survival of patients with squamous cell carcinoma of the cervix treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 75(3):S370, 2009. PMID: None.
Klopp A, Watson K, Munshi A, Spaeth E, Meyn R, Andreeff M, Marini F. MSC do not accelerate local tumor growth when limited 10% or less of tumor cells but do increase tumor resistance to radiation. AACR Meeting Abstracts:4836, 2008. PMID: None.
Klopp A, Spaeth E, Dembinski J, Meyn R, Munshi A, Cox J, Andreeff M, Marini F. Radiation enhances engraftment of mesenchymal stem cells in murine 4T1 tumors. AACR Meeting Abstracts:1329, 2007. PMID: None.
Klopp AH, Chang JY, Liu H, Balter PA, Macapinlac H, Komaki R, Cox JD. Intra-thoracic patterns of failure for non-small cell lung cancer (NSCLC) with PET/CT-defined target delineation. Int J Radiat Oncol Biol Phys 66(3):S467, 2006. PMID: None.
Eifel PJ, Klopp AH, Ramondetta LM, Gershenson DM, Jhingran A. Node-positive adenocarcinoma of the endometrium: Outcome and patterns of recurrence. Int J Radiat Oncol Biol Phys 66(3):S166, 2006. PMID: None.

Book Chapters

Eifel, PJ, Klopp, AH, Berek, JS, Konstantinopoulos, PA. Cancer of the cervix, vagina, and vulva, 1172-1210, 2018.
Klopp, AH, Eifel, PJ. Endometrium, 559-575, 2017.
Klopp, AH, Eifel, PJ, Berek, JS, Konstantinopoulos, PA. Cancer of the cervix, vagina, and vulva, None, 2015.
Klopp AH, Eifel PJ, Berek JS, Konstantinopoulous PA. Cancer of the cervix, vagina, and vulva. In: DeVita, Hellman, and Rosenberg's Cancer Principles & Practice. 10th. Wolters Kluwer Health, 1013-1047, 2015.
Klopp AH, Eifel PJ. Ovary, Uterus (Fallopian Tube, Cervix), Vagina and Vulva. In: ALERT - Adverse Late Effects of Cancer Treatment. None. Springer-Verlag, 551-570, 2014.
Lu, KH, Klopp, AH, Soliman, PT, Schmandt, R. Increased adiposity and endometrial cancer risk, 53-69, 2013.
Lu KH, Klopp AH, Soliman PT, and Schmandt RE. Increased Adiposity and Endometrial Cancer Risk. In: Adipose Tissue and Cancer. None. Springer, 53-70, 2013.
Klopp, AH, Jhingran, A. Field cancerization in vulvar, vaginal and cervical epithelia, 415-422, 2011.
Klopp AH, Jhingran A. Field cancerization in vulvar, vaginal, and cervical epithelia. In: Field Cancerization: Basic Science and Clinical Applications. None. Nova Science Publications, 415-421, 2011.

Books (edited and written)

Eifel PJ, Klopp AH. Gynecologic Radiation Oncology: A Practical Guide. Ed(s) 1. Wolters Kluwer, 2016.
Berger NA, Klopp AH, Lu K. Focus on Gynecologic Malignancies. Ed(s) None. Springer, 2016.

Letters to the Editor

Eifel, PJ, Klopp, AH. In reply to Keenan et al. Anatomic principles as the basis of target volume definition. Radiotherapy and Oncology 136: 198-199, 2019.
Eifel PJ, Klopp AH. In reply to Keenan et al. Anatomic principles as the basis of target volume definition. None 136: 198-199, 2019.

Less

Selected Presentations & Talks

Local Presentations

2024. Experience with Radiation Treatment. Invited. Mesonephric-like Adenocarcinoma (MLA) Conference. Houston, Texas, US.
2019. Molecular drivers of radiation response in cervical cancer. Invited. Grand Rounds. Houston, Texas, US.
2019. Quantitative Imaging & Parameter Mapping. Conference. Quantitative Imaging & Parameter Mapping. Houston, TX, US.
2018. Management of Endometrial Cancer (SAM). Conference. Management of Endometrial Cancer (SAM). Houston, TX, US.
2016. Radiation Therapy for Endometrial Cancer. Conference. Radiation Therapy for Endometrial Cancer. Houston, TX, US.
2015. Improving outcomes in gynecologic cancers with image-guided radiation therapy. Conference. Improving outcomes in gynecologic cancers with image-guided radiation therapy. Houston, TX, US.
2014. Treatment Guidelines for Endometrial Cancer. Conference. Treatment Guidelines for Endometrial Cancer. Houston, TX, US.
2014. Obesity Promotes Growth of Ovarian Cancer through Adipose Stem Cells. Conference. Obesity Promotes Growth of Ovarian Cancer through Adipose Stem Cells. Houston, TX, US.
2012. Radiation therapy in gynecologic cancers. Conference. Radiation therapy in gynecologic cancers. Houston, TX, US.
2011. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Conference. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Houston, TX, US.
2011. Omental adipose derived stem cells in the endometrial and ovarian cancer microenvironment. Conference. Omental adipose derived stem cells in the endometrial and ovarian cancer microenvironment. Houston, TX, US.
2006. Radiation treatment for lung cancer at MDACC; Representative cases. Conference. Radiation treatment for lung cancer at MDACC; Representative cases. Houston, TX, US.

Regional Presentations

2022. IMMUNOCERV, an ongoing Phase II trial combining PDS0101, an HPV-specific T cell immunotherapy, with chemotherapy and radiation for treatment of locally advanced cervical cancers. Conference. IMMUNOCERV, an ongoing Phase II trial combining PDS0101, an HPV-specific T cell immunotherapy, with chemotherapy and radiation for treatment of locally advanced cervical cancers. Boston, MA, US.
2021. MGH Faculty Mentorship. Conference. MGH Faculty Mentorship, US.
2021. COVID VACCINE at MDACC. Conference. COVID VACCINE at MDACC, US.
2021. Lunch & Learn: Covid-19 vaccines for cancer patients. Conference. Lunch & Learn: Covid-19 vaccines for cancer patients, US.
2014. Radiation Oncology Overview. Conference. Radiation Oncology Overview. Montgomery, TX, US.
2012. Clinical Research Development Plan, Section of Gynecology. Conference. Clinical Research Development Plan, Section of Gynecology. Round Top, TX, US.
2010. Current management of endometrial malignancies. Conference. Current management of endometrial malignancies. The Woodlands, TX, US.

National Presentations

2024. PRO/QoL/Survivorship 2: Quick Pitch "Oral Scientific Session "Targeting Provider Wellness for Exceptional Patient Care". Invited. ASTRO. Washington, DC, Maryland, US.
2024. GYN Brachytherapy in the Era of Patient-Specific Medicine: Molecular Subtypes of Uterine Cancer. Invited. World Congress of Brachytherapy. National Harbor, Maryland, US.
2024. Endometrial trials and adjuvant therapy decisions. Invited. Washington University, US.
2023. Microbiome Predictors of Tumor Response to Radiation. Conference. ASTRO. San Diego, CA, US.
2023. Update on IMMUNOCERV Trial: HPV directed vaccine in locally advanced cervical cancer. Conference. NRG Semiannual Meeting. Philadelphia, PA, US.
2023. Microbiome Predictors of Radiation Treatment Response and Toxicity in Cervical Cancer. Conference. NRG Semiannual Meeting. Philadelphia, PA, US.
2022. Endometrial Cancer: Stage IIIC Disease and Molecular Testing. Conference. Endometrial Cancer: Stage IIIC Disease and Molecular Testing. San Antonio, TX, US.
2022. RANDOMIZED TRIAL OF PELVIC RADIATION WITH AND WITHOUT CONCURRENT CISPLATIN IN PATIENTS WITH A PELVIC ONLY RECURRENCE OF ENDOMETRIAL CANCER. Conference. RANDOMIZED TRIAL OF PELVIC RADIATION WITH AND WITHOUT CONCURRENT CISPLATIN IN PATIENTS WITH A PELVIC ONLY RECURRENCE OF ENDOMETRIAL CANCER. New York City, NY, US.
2022. Debate: Is There Still a Role for Radiation Therapy in Stage III-IV Endometrial cancer? (PRO). Conference. Debate: Is There Still a Role for Radiation Therapy in Stage III-IV Endometrial cancer? (PRO). Phoenix, AZ, US.
2021. Long-term follow up of RTOG 1203. Conference. Long-term follow up of RTOG 1203, US.
2021. Radiation Therapy in Endometrial Cancer: Refining the Anatomic and Molecular target. Conference. American College of Radiation Oncology (ACRO), US.
2021. ACRO2021 Virtual Resident Symposium "SBRT". Conference. American College of Radiation Oncology ACRO), US.
2021. Endometrial cancer radiation therapy: Refining the molecular and anatomic target. Conference. American College of Radiation Oncology (ACRO), US.
2021. Adjuvant treatment for stage 1-3 Endometrial cancer. Conference. ACRO2021 Annual Meeting, US.
2021. Ask a Radiation Oncologist: Cervical Cancer Facebook Live Event!. Conference. ASTRO - Ask a Radiation Oncologist: Cervical Cancer Facebook Live Event!. Virtual, US.
2020. Update in Endometrial cancer radiation. Conference. American Society for Radiation Oncology (ASTRO), US.
2020. Of Bugs and Drugs: How Our Microbiome Saves Us?. Conference. American Society of Clinical Oncology (ASCO) Annual Virtual meeting, US.
2019. The Microbiota and radiotherapy in cervical cancer. Conference. The Microbiota and radiotherapy in cervical cancer. New York, NY, US.
2019. Microbiome in HPV cancers: Predictor of response and toxicity. Conference. Microbiome in HPV cancers: Predictor of response and toxicity. Milwaukee, WI, US.
2019. Controversies in Uterine Cancer. Conference. Controversies in Uterine Cancer. Miami, FL, US.
2018. Clonal Expansion of Antigen Specific T-cells during Radiation Therapy for HPV associated Cervical Cancers is Regulated by the Vaginal Microbiome. Conference. Clonal Expansion of Antigen Specific T-cells during Radiation Therapy for HPV associated Cervical Cancers is Regulated by the Vaginal Microbiome. Washington, DC, US.
2018. Uterine Corpus. Conference. The GOG Foundation. Philadelphia, PA, US.
2018. Advanced Endometrial Cancer...Does Radiation Still Have a Role?. Conference. Advanced Endometrial Cancer...Does Radiation Still Have a Role?. New Orleans, LA, US.
2018. Advanced Endometrial Cancer...Does Radiation Still Have a Role?. Conference. Advanced Endometrial Cancer...Does Radiation Still Have a Role?. Pitkin, CO, US.
2018. Clonal Expansion of Antigen Specific T-cells during Radiation Therapy for HPV associated Cervical Cancers is Regulated by the Vaginal Microbiome. Conference. Clonal Expansion of Antigen Specific T-cells during Radiation Therapy for HPV associated Cervical Cancers is Regulated by the Vaginal Microbiome. Wa, US.
2017. IMRT for Postoperative Treatment of Uterine and Cervical Cancer, Plenary Session. Conference. IMRT for Postoperative Treatment of Uterine and Cervical Cancer, Plenary Session. San Diego, CA, US.
2017. Rectal Microbiome Diversity Predicts Disease Response at Completion of Radiation Therapy for Squamous Cell Carcinoma of the Cervix, Scientific Session. Conference. Rectal Microbiome Diversity Predicts Disease Response at Completion of Radiation Therapy for Squamous Cell Carcinoma of the Cervix, Scientific Session. San Diego, CA, US.
2017. Increased Diversity of the Intestinal Microbiome Predicts for Lower Rates of Patient Reported Acute Gastrointestinal Toxicity in Women Receiving Radiation Therapy for Cervical Cancer. Conference. Increased Diversity of the Intestinal Microbiome Predicts for Lower Rates of Patient Reported Acute Gastrointestinal Toxicity in Women Receiving Radiation Therapy for Cervical Cancer. San Diego, CA, US.
2016. Barretos/MDACC/UCLA Hands on Sessions for Head/Neck, CNS, Breast and GYN "Improving Patient Care by Improving Knowledge". Conference. Barretos/MDACC/UCLA Hands on Sessions for Head/Neck, CNS, Breast and GYN "Improving Patient Care by Improving Knowledge". Barretos, Brazil, US.
2016. Translational Research Committee Brainstorming Meeting. Conference. Translational Research Committee Brainstorming Meeting. Lisbon, Portugal, US.
2016. Development of a Radiomics-based survival prediction model for cervical cancer patients. Conference. Development of a Radiomics-based survival prediction model for cervical cancer patients. Boston, MA, US.
2016. A Phase III randomized trial comparing reported toxicity and quality of life (QOL) during pelvic IMRT as Compared to conventional radiation therapy. Conference. A Phase III randomized trial comparing reported toxicity and quality of life (QOL) during pelvic IMRT as Compared to conventional radiation therapy. Boston, MA, US.
2015. Definitive extended-field radiation therapy for cervical cancer patients with para-aortic lymph node metastases. Conference. Definitive extended-field radiation therapy for cervical cancer patients with para-aortic lymph node metastases. San Antonio, TX, US.
2015. Recent advances in endometrial cancer. Conference. Recent advances in endometrial cancer. San Antonio, TX, US.
2015. Innovative approaches to difficult GYN cases. Conference. Innovative approaches to difficult GYN cases. Orlando, FL, US.
2015. External Beam Radiation Therapy - How Conformal and Precisely Focused Should We Be?. Conference. External Beam Radiation Therapy - How Conformal and Precisely Focused Should We Be?. Chicago, IL, US.
2014. Controversies in the Management of Endometrial Cancer, Educational Session. Conference. Controversies in the Management of Endometrial Cancer, Educational Session. San Francisco, CA, US.
2014. Brachytherapy versus external beam for endometrial cancer. Conference. Brachytherapy versus external beam for endometrial cancer. Chicago, IL, US.
2014. The role of postoperative radiation therapy in endometrial cancer: after GOG 249. Conference. The role of postoperative radiation therapy in endometrial cancer: after GOG 249. Chicago, IL, US.
2014. Difficult cases in gynecology. Conference. Difficult cases in gynecology. St. Thomas.
2014. Current recommendations in endometrial carcinoma. Conference. Current recommendations in endometrial carcinoma. San Diego, CA, US.
2014. Brachytherapy. Conference. Brachytherapy. St. Thomas.
2014. Obesity and related mechanisms. Conference. Obesity and related mechanisms. Boston, MA, US.
2014. When is pelvic radiotherapy indicated for endometrial cancer?. Conference. When is pelvic radiotherapy indicated for endometrial cancer?. Orlando, FL, US.
2013. Obesity promotes growth of ovarian cancer through adipose stem cells. Conference. Obesity promotes growth of ovarian cancer through adipose stem cells. Miami, FL, US.
2013. Human omental-derived adipose stem cells: Modulator of ovarian cancer proliferation, migration, and chemoresistance. Conference. Human omental-derived adipose stem cells: Modulator of ovarian cancer proliferation, migration, and chemoresistance. Miami, FL, US.
2013. Controversies in the Management of Endometrial Cancer, Educational Session. Conference. Controversies in the Management of Endometrial Cancer, Educational Session. Atlanta, GA, US.
2013. GYN Proffered Papers Scientific Session Moderator. Conference. GYN Proffered Papers Scientific Session Moderator. New Orleans, LA, US.
2012. Radiation therapy in the management of carcinosarcoma of the uterus. Conference. Radiation therapy in the management of carcinosarcoma of the uterus. Boston, MA, US.
2012. Difficult cases in endometrial and vaginal cancer, Educational Session. Conference. Difficult cases in endometrial and vaginal cancer, Educational Session. Boston, MA, US.
2012. Biologic basis to radiation resistance - Opportunities for new strategies to enhance effect of radiation in cervical cancer. Conference. Biologic basis to radiation resistance - Opportunities for new strategies to enhance effect of radiation in cervical cancer. San Diego, CA, US.
2011. Human omental-derived adipose stem cells decrease ovarian tumor radiosensitivity, promote ovarian tumor proliferation, migration and Growth. Conference. Human omental-derived adipose stem cells decrease ovarian tumor radiosensitivity, promote ovarian tumor proliferation, migration and Growth. Miami Beach, FL, US.
2011. Difficult cases in GYN management. Conference. Difficult cases in GYN management. Miami Beach, FL, US.
2011. Difficult cases. Conference. Difficult cases. San Diego, CA, US.
2010. Hematologic toxicity on RTOG 0418: A phase II study of post-operative IMRT for gynecologic cancer. Conference. Hematologic toxicity on RTOG 0418: A phase II study of post-operative IMRT for gynecologic cancer. San Diego, CA, US.
2010. Difficult cases in GYN management. Conference. Difficult cases in GYN management. San Diego, CA, US.
2010. Grid-based Boltzmann Solver (GBBS) Vs TG-43 for Ir-192 HDR intracavitary brachytherapy: A retrospective dosimetric study. Conference. Grid-based Boltzmann Solver (GBBS) Vs TG-43 for Ir-192 HDR intracavitary brachytherapy: A retrospective dosimetric study. Philadelphia, PA, US.
2010. Using MRI-based deformable image registration to accumulate 3D total dose distribution from intracavitary brachytherapy fractions of cervical cancer. Conference. Using MRI-based deformable image registration to accumulate 3D total dose distribution from intracavitary brachytherapy fractions of cervical cancer. Philadelphia, PA, US.
2010. Grid based boltzmann solver for brachytherapy treatment planning. Conference. Grid based boltzmann solver for brachytherapy treatment planning. Las Vegas, NV, US.
2010. Pilot study of a new CT-compatible intracavitary brachytherapy applicator for treatment of cervical cancer. Conference. Pilot study of a new CT-compatible intracavitary brachytherapy applicator for treatment of cervical cancer. Atlanta, GA, US.
2009. Difficult management in GYN cases. Conference. Difficult management in GYN cases. Chicago, IL, US.
2009. Galectin-7 is a prognostic factor for radiation response in squamous cell carcinoma of the cervix. Conference. Galectin-7 is a prognostic factor for radiation response in squamous cell carcinoma of the cervix. Chicago, IL, US.
2009. Impact of mesenchymal stem cells on radiation response. Conference. Impact of mesenchymal stem cells on radiation response. Savannah, GA, US.
2009. Quantification of CT artifact reduction of second generation intracavitary brachytherapy applicator. Conference. Quantification of CT artifact reduction of second generation intracavitary brachytherapy applicator. Anaheim, CA, US.
2009. Mesenchymal stem cells impact tumor response to radiation therapy. Conference. Mesenchymal stem cells impact tumor response to radiation therapy. Denver, CO, US.
2008. Mesenchymal stem cells engraft at higher levels in irradiated tumors and can impact tumor response to radiation. Conference. Mesenchymal stem cells engraft at higher levels in irradiated tumors and can impact tumor response to radiation. Boston, MA, US.
2008. MSC do not accelerate local tumor growth when limited 10% or less of tumor cells but do increase tumor resistance to radiation. Conference. MSC do not accelerate local tumor growth when limited 10% or less of tumor cells but do increase tumor resistance to radiation. San Diego, CA, US.
2007. Radiation enhances engraftment of mesenchymal stem cells in murine 4T1 tumors. Conference. Radiation enhances engraftment of mesenchymal stem cells in murine 4T1 tumors. San Francisco, CA, US.
2007. Radiation enhances engraftment of mesenchymal stem cells in murine 4T1 tumors. Conference. Radiation enhances engraftment of mesenchymal stem cells in murine 4T1 tumors. Los Angeles, CA, US.
2006. Intra-thoracic patterns of failure for non-small cell lung cancer (NSCLC) with PET/CT-defined target delineation. Conference. Intra-thoracic patterns of failure for non-small cell lung cancer (NSCLC) with PET/CT-defined target delineation. Philadelphia, PA, US.
2006. Node-positive adenocarcinoma of the endometrium: Outcome and patterns of recurrence. Conference. Node-positive adenocarcinoma of the endometrium: Outcome and patterns of recurrence. Philadelphia, PA, US.
2006. Gene expression changes in cervical cancers after initiation of chemoradiation and correlation with clinical outcome. Conference. Gene expression changes in cervical cancers after initiation of chemoradiation and correlation with clinical outcome. Maui, HI, US.
2000. Virally encoded cyclin is required for reactivation from latency. Conference. Virally encoded cyclin is required for reactivation from latency. Aspen, CO, US.
2000. Role of MHV-68 encoded viral cyclin. Conference. Role of MHV-68 encoded viral cyclin. Aspen, CO, US.

International Presentations

2024. Role of imaging and biomarkers in gynecological cancer: Immunoserv Study. Invited. GEC ESTRO GYN Network Meeting, US.
2024. Paradigm shift of radiotherapy treatment in endometrial cancer based on the new FIGO2023 staging and molecular subtypes. Invited. Thai Society of Therapeutic Radiology and Oncology (THASTRO), TH.
2023. Endometrial cancer in the molecular era – can we escalate/de-escalate treatment? – The radio-oncologist's point of view. Invited. IV Brazilian Oncology Week. Rio de Janeiro, BR.
2022. Metagenomic predictors of radiation treatment response in cervical cancer. Invited, CN.
2022. Metagenomic predictors of radiation treatment response in cervical cancer. Invited. Youth Salon of Brachytherapy Special Committee of Chinese Anti-Cancer Association, CN.
2015. IMRT: Stargate to more intense chemotherapy schedules? Special session: New trends in cervical cancer chemotherapy and radiation oncology. Conference. IMRT: Stargate to more intense chemotherapy schedules? Special session: New trends in cervical cancer chemotherapy and radiation oncology, AT.
2012. How important are tumour and normal tissue stem cells in radiation therapy, Moderator. Conference. How important are tumour and normal tissue stem cells in radiation therapy, Moderator. Barcelona, ES.
2009. Mesenchymal stromal cells engraft in preferentially in irradiated tumors and impact tumor response to radiation. Conference. Mesenchymal stromal cells engraft in preferentially in irradiated tumors and impact tumor response to radiation, CH.

Formal Peers

2023. Longitudinal Multihomic Profiling of Cervical Cancer. Invited. Longitudinal Multihomic Profiling of Cervical Cancer. Annandale, VA, US.
2023. Uncovering the Dynamic Changes in Cervical Cancers: Longitudinal Multiomic Profiling during Radiation Therapy. Invited. Uncovering the Dynamic Changes in Cervical Cancers: Longitudinal Multiomic Profiling during Radiation Therapy. New York City, NY, US.
2022. Uterine clear cell and undifferentiated cancers: updates/unanswered questions. Invited. Uterine clear cell and undifferentiated cancers: updates/unanswered questions. Baltimore, MD, US.
2022. Management of Stage IVA Cervical Cancers. Invited. Management of Stage IVA Cervical Cancers, AU.
2022. New Horizons to Improve Outcomes in Cervical Cancer: Imaging, Interstitial Needles and Immunotherapy. Invited. New Horizons to Improve Outcomes in Cervical Cancer: Imaging, Interstitial Needles and Immunotherapy. Philadelphia, PA, US.
2021. Endometrial Cancer. Invited. Endometrial Cancer, US.
2021. Adjuvant treatment for stage 1-3 Endometrial cancer. Invited. Adjuvant treatment for stage 1-3 Endometrial cancer. Virtual, US.
2019. The Role of the Microbiome in Treatment Response for Gynecologic Cancers. Invited. The Role of the Microbiome in Treatment Response for Gynecologic Cancers, US.
2016. Radiographic and Metagenomic Predicators of Radiation Response in Cervical Cancer. Invited. Radiographic and Metagenomic Predicators of Radiation Response in Cervical Cancer. Stanford, CA, US.
2014. Radiation Oncology in endometrial cancer. Invited. Radiation Oncology in endometrial cancer. Houston, TX, US.
2013. A difficult case of intracavitary brachytherapy for advanced cervical cancer requiring multiple revisions due to distorted uterine anatomy. Invited. A difficult case of intracavitary brachytherapy for advanced cervical cancer requiring multiple revisions due to distorted uterine anatomy. Houston, TX, US.
2013. Improving outcomes in endometrial cancer with radiation; Update on best evidence for treatment indications and approach. Invited. Improving outcomes in endometrial cancer with radiation; Update on best evidence for treatment indications and approach. Houston, TX, US.
2012. Visceral adipose derived stem cells in the microenvironment of ovarian and endometrial cancers. Invited. Visceral adipose derived stem cells in the microenvironment of ovarian and endometrial cancers. Houston, TX, US.
2011. Role of radiation therapy in management of gynecologic cancer. Invited. Role of radiation therapy in management of gynecologic cancer. Oaklawn, IL, US.
2011. Adipose and bone marrow derived stem cells in the tumor microenvironment. Invited. Adipose and bone marrow derived stem cells in the tumor microenvironment. Houston, TX, US.
2010. Bone marrow and adipose derived stem cells in the tumor microenvironment. Invited. Bone marrow and adipose derived stem cells in the tumor microenvironment. Houston, TX, US.
2010. Tumor microenvironment effects on cancer stem cells and radiosensitivity. Invited. Tumor microenvironment effects on cancer stem cells and radiosensitivity. Houston, TX, US.
2009. XRT for endometrial cancer. Invited. XRT for endometrial cancer. Houston, TX, US.

Less

Grant & Contract Support

Title:	Project 3-Treat MRD
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Co-PI

Title:	Project 2-Microbiome
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Co-PI

Title:	The Impact of Biological Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia
Funding Source:	NIH/NCI
Role:	Collaborator

Title:	2019-1260 IMMUNOCERV Evaluating the Safety of Chemoradiation Combined with PDS0101 Immunotherapy in Treating Locally Advanced Cervical Cancer
Funding Source:	PDS Biotechnology Corp
Role:	PI

Title:	Integration of Magnetic Resonance Imaging and Blood-based Human Papillomavirus (HPV) DNA Genotyping to Predict Response to Chemoradiotherapy in Cervical Cancer (IMPACT)
Funding Source:	NIH/NCI
Role:	PI

Title:	Defining a globally accessible and pragmatic predictive signature (GAPPS) for locally advanced cervical cancer
Funding Source:	NIG
Role:	PI

Title:	Moon Shot Treat MRD
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Co-PI

Title:	Moon Shot Microbiome
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Co-PI

Title:	Moon Shot HPV Antigenicity
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Co-PI

Title:	Moon Shot Antigenicity
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Investigator

Title:	Moon Shot Microbiome
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Investigator

Title:	Moon Shot Biomarker Discovery
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Co-I

Title:	Moon Shot HPV Antigenicity
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Co-PI

Title:	Moon Shot Microbiome
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Co-PI

Title:	(ROSI) Radiation Oncology Strategic Initiatives Award
Funding Source:	The University of Texas MD Anderson Cancer Center, Division of Radiation Oncology
Role:	PI

Title:	CCSG supplement: impact of HIV on Immune Activation and Microbiome in Cervical Cancers during Radiation Therapy
Funding Source:	NIH/NCI
Role:	PI

Title:	Critical Components of the Microbiome to Support T-Cell Expansion during Radiation Therapy for HPV Cancers
Funding Source:	Emerson Collective
Role:	PI

Title:	Moon Shot HPV Antigenicity
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Co-I

Title:	The Cervical Cancer Microbiome: Driver of Malignant Progression and Treatment Resistance?
Funding Source:	SINF
Role:	PI

Title:	The cervical cancer microbiome: driver of malignant progression and treatment resistance
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	PI

Title:	MRI-Guided Gynecologic Brachytherapy: Addressing Critical Unmet Clinical Needs for Image-Guided Adaptive Therapy
Funding Source:	NIH/NCI and Radiation Oncology and Cancer Imaging Program
Role:	Co-PI

Title:	Beige adipose tissue and ovarian cancer progression: The role of Interleukin-6
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	PI

Title:	Where it's at: The effect of adipose tissue location on cancer progression
Funding Source:	American Cancer Society (ACS)
Role:	PI

Title:	Cancer Center Support (CORE) Grant
Funding Source:	NIH/NCI
Role:	Co-I

Title:	Study of biomarkers in ovarian cancer: modulation by activity and intervention
Funding Source:	NIH/NCI
Role:	Co-I

Title:	Where it's at: The effect of adipose tissue location on cancer progression
Funding Source:	American Cancer Society (ACS)
Role:	PI

Title:	A Missing Link Between Obesity and Cancer: Adipose Derived Stem Cells
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI

Title:	Visceral obesity and ovarian cancer: what is the role of adipose stem cells?
Funding Source:	MD Anderson Cancer Center
Role:	PI

Title:	Visceral Adipose Derived Stem Cells: Mediator of Poor Outcome in Centrally Obese Patients with Ovarian Cancer
Funding Source:	UTMDACC SPORE in Ovarian Developmental Research Award (DRP)
Role:	PI

Title:	MicroRNA as a prognostic marker in cervical cancer patients after chemoradiation: Analysis of tissues from RTOG 90-01 and an institutional prospective trial
Funding Source:	Radiological Society of North America (RSNA)
Role:	Scientific Advisor

Title:	Visceral adipose stem cells in the endometrial cancer microenvironment
Funding Source:	UTMDACC Uterine SPORE Career Development Award
Role:	PI

Title:	Adipose tissue as a source of stem cells to promote ovarian cancer
Funding Source:	Liz Tilberis Scholars Program Grant Award, Ovarian Cancer Research Fund
Role:	PI

Title:	Tumor-tropic mesenchymal stem cells as a vehicle to deliver radiation sensitizers in ovarian cancer
Funding Source:	American Cancer Society (ACS)
Role:	PI

CV information above last modified January 24, 2025

Ann H. Klopp, M.D., Ph.D.

About Dr. Klopp

In the News

4 questions about COVID-19 vaccines and bivalent boosters, answered

Present Title & Affiliation

Primary Appointment

Research Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Selected Publications

Peer-Reviewed Articles

Invited Articles

Other Articles

Editorials

Abstracts

Book Chapters

Books (edited and written)

Letters to the Editor

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Related Links

Klopp Laboratory

Help #EndCancer

Ann H. Klopp, M.D., Ph.D.

About Dr. Klopp

In the News

4 questions about COVID-19 vaccines and bivalent boosters, answered

Present Title & Affiliation

Primary Appointment

Research Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Selected Publications

Peer-Reviewed Articles

Invited Articles

Other Articles

Editorials

Abstracts

Book Chapters

Books (edited and written)

Letters to the Editor

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Request an Appointment

Related Links

Klopp Laboratory

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer